--- Final BPE Model Predictions ---

Example 1:
[CLS]                O                    O                   
Emergent             O                    O                   
care                 O                    O                   
note                 O                    O                   
:                    O                    O                   
Patient              O                    O                   
found                O                    O                   
unresponsive         O                    O                   
.                    O                    O                   
Medical              O                    O                   
alert                O                    O                   
bracelet             O                    O                   
indicates            O                    O                   
migraine             B-DISEASE            B-DISEASE           
.                    O                    O                   
EMS                  O                    O                   
administered         O                    O                   
naloxone             O                    O                   
without              O                    O                   
effect               O                    O                   
.                    O                    O                   
Family               O                    O                   
arrived              O                    O                   
and                  O                    O                   
confirmed            O                    O                   
patient              O                    O                   
takes                O                    O                   
pembrolizumab        B-MEDICATION         B-MEDICATION        
for                  O                    O                   
the                  O                    O                   
condition            O                    O                   
.                    O                    O                   
Transported          O                    O                   
to                   O                    O                   
ICU                  O                    O                   
for                  O                    O                   
further              O                    O                   
management           O                    O                   
of                   O                    O                   
status               O                    O                   
epilepticus          O                    O                   
secondary            O                    O                   
to                   O                    O                   
migraine             B-DISEASE            B-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 2:
[CLS]                O                    O                   
Assessment           O                    O                   
and                  O                    O                   
Plan                 O                    O                   
:                    O                    O                   
#                    O                    O                   
colon                B-DISEASE            B-DISEASE           
cancer               I-DISEASE            I-DISEASE           
-                    O                    O                   
largely              O                    O                   
controlled           O                    O                   
but                  O                    O                   
recent               O                    O                   
stress               O                    O                   
has                  O                    O                   
caused               O                    O                   
an                   O                    O                   
uptick               O                    O                   
in                   O                    O                   
symptoms             O                    O                   
.                    O                    O                   
We                   O                    O                   
will                 O                    O                   
increase             O                    O                   
the                  O                    O                   
dosage               O                    O                   
of                   O                    O                   
sertraline           B-MEDICATION         B-MEDICATION        
from                 O                    O                   
10mg                 O                    O                   
to                   O                    O                   
20mg                 O                    O                   
daily                O                    O                   
.                    O                    O                   
Patient              O                    O                   
was                  O                    O                   
advised              O                    O                   
to                   O                    O                   
monitor              O                    O                   
for                  O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
#                    O                    O                   
Hypertension         O                    O                   
-                    O                    O                   
stable               O                    O                   
.                    O                    O                   
#                    O                    O                   
Diabetes             O                    O                   
-                    O                    O                   
diet                 O                    O                   
controlled           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 3:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
methotrexate         B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
vertigo              B-DISEASE            B-DISEASE           
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
methotrexate         B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 4:
[CLS]                O                    O                   
Discharge            O                    O                   
Summary              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
was                  O                    O                   
admitted             O                    O                   
for                  O                    O                   
an                   O                    O                   
acute                O                    O                   
exacerbation         O                    O                   
of                   O                    O                   
meningitis           B-DISEASE            B-DISEASE           
.                    O                    O                   
During               O                    O                   
the                  O                    O                   
hospital             O                    O                   
stay                 O                    O                   
,                    O                    O                   
symptoms             O                    O                   
were                 O                    O                   
initially            O                    O                   
managed              O                    O                   
with                 O                    O                   
IV                   O                    O                   
fluids               O                    O                   
and                  O                    O                   
subsequently         O                    O                   
transitioned         O                    O                   
to                   O                    O                   
oral                 O                    O                   
ciprofloxacin        B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
is                   O                    O                   
stable               O                    O                   
for                  O                    O                   
discharge            O                    O                   
and                  O                    O                   
instructed           O                    O                   
to                   O                    O                   
follow               O                    O                   
up                   O                    O                   
with                 O                    O                   
primary              O                    O                   
care                 O                    O                   
for                  O                    O                   
monitoring           O                    O                   
of                   O                    O                   
meningitis           B-DISEASE            B-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 5:
[CLS]                O                    O                   
Dermatology          O                    O                   
consult              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
presents             O                    O                   
with                 O                    O                   
a                    O                    O                   
diffuse              O                    O                   
rash                 O                    O                   
.                    O                    O                   
Differential         O                    O                   
diagnosis            O                    O                   
includes             O                    O                   
drug                 O                    O                   
eruption             O                    O                   
from                 O                    O                   
recent               O                    O                   
initiation           O                    O                   
of                   O                    O                   
lisinopril           B-MEDICATION         B-MEDICATION        
versus               O                    O                   
cutanous             O                    O                   
manifestation        O                    O                   
of                   O                    O                   
underlying           O                    O                   
sleep                B-DISEASE            B-DISEASE           
apnea                I-DISEASE            I-DISEASE           
.                    O                    O                   
Biopsy               O                    O                   
performed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 6:
[CLS]                O                    O                   
Discharge            O                    O                   
Summary              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
was                  O                    O                   
admitted             O                    O                   
for                  O                    O                   
an                   O                    O                   
acute                O                    O                   
exacerbation         O                    O                   
of                   O                    O                   
osteoporosis         B-DISEASE            B-DISEASE           
.                    O                    O                   
During               O                    O                   
the                  O                    O                   
hospital             O                    O                   
stay                 O                    O                   
,                    O                    O                   
symptoms             O                    O                   
were                 O                    O                   
initially            O                    O                   
managed              O                    O                   
with                 O                    O                   
IV                   O                    O                   
fluids               O                    O                   
and                  O                    O                   
subsequently         O                    O                   
transitioned         O                    O                   
to                   O                    O                   
oral                 O                    O                   
jardiance            B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
is                   O                    O                   
stable               O                    O                   
for                  O                    O                   
discharge            O                    O                   
and                  O                    O                   
instructed           O                    O                   
to                   O                    O                   
follow               O                    O                   
up                   O                    O                   
with                 O                    O                   
primary              O                    O                   
care                 O                    O                   
for                  O                    O                   
monitoring           O                    O                   
of                   O                    O                   
osteoporosis         B-DISEASE            B-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 7:
[CLS]                O                    O                   
The                  O                    O                   
62                   O                    O                   
-                    O                    O                   
year                 O                    O                   
-                    O                    O                   
old                  O                    O                   
female               O                    O                   
patient              O                    O                   
with                 O                    O                   
a                    O                    O                   
history              O                    O                   
of                   O                    O                   
melanoma             B-DISEASE            B-DISEASE           
returns              O                    O                   
for                  O                    O                   
routine              O                    O                   
follow               O                    O                   
-                    O                    O                   
up                   O                    O                   
.                    O                    O                   
She                  O                    O                   
states               O                    O                   
that                 O                    O                   
the                  O                    O                   
gabapentin           B-MEDICATION         B-MEDICATION        
prescribed           O                    O                   
at                   O                    O                   
the                  O                    O                   
last                 O                    O                   
visit                O                    O                   
has                  O                    O                   
significantly        O                    O                   
reduced              O                    O                   
her                  O                    O                   
pain                 O                    O                   
levels               O                    O                   
.                    O                    O                   
However              O                    O                   
,                    O                    O                   
she                  O                    O                   
is                   O                    O                   
concerned            O                    O                   
about                O                    O                   
potential            O                    O                   
long                 O                    O                   
-                    O                    O                   
term                 O                    O                   
interactions         O                    O                   
between              O                    O                   
gabapentin           B-MEDICATION         B-MEDICATION        
and                  O                    O                   
her                  O                    O                   
other                O                    O                   
supplements          O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 8:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
bupropion            B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
sleep                B-DISEASE            B-DISEASE           
apnea                I-DISEASE            I-DISEASE           
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
bupropion            B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 9:
[CLS]                O                    O                   
Assessment           O                    O                   
and                  O                    O                   
Plan                 O                    O                   
:                    O                    O                   
#                    O                    O                   
hepatitis            B-DISEASE            B-DISEASE           
b                    I-DISEASE            O                   
-                    O                    O                   
largely              O                    O                   
controlled           O                    O                   
but                  O                    O                   
recent               O                    O                   
stress               O                    O                   
has                  O                    O                   
caused               O                    O                   
an                   O                    O                   
uptick               O                    O                   
in                   O                    O                   
symptoms             O                    O                   
.                    O                    O                   
We                   O                    O                   
will                 O                    O                   
increase             O                    O                   
the                  O                    O                   
dosage               O                    O                   
of                   O                    O                   
isoniazid            B-MEDICATION         B-MEDICATION        
from                 O                    O                   
10mg                 O                    O                   
to                   O                    O                   
20mg                 O                    O                   
daily                O                    O                   
.                    O                    O                   
Patient              O                    O                   
was                  O                    O                   
advised              O                    O                   
to                   O                    O                   
monitor              O                    O                   
for                  O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
#                    O                    O                   
Hypertension         O                    O                   
-                    O                    O                   
stable               O                    O                   
.                    O                    O                   
#                    O                    O                   
Diabetes             O                    O                   
-                    O                    O                   
diet                 O                    O                   
controlled           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 10:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
fibromyalgia         B-DISEASE            B-DISEASE           
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
fentanyl             B-MEDICATION         B-MEDICATION        
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
fibromyalgia         B-DISEASE            B-DISEASE           
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 11:
[CLS]                O                    O                   
Dermatology          O                    O                   
consult              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
presents             O                    O                   
with                 O                    O                   
a                    O                    O                   
diffuse              O                    O                   
rash                 O                    O                   
.                    O                    O                   
Differential         O                    O                   
diagnosis            O                    O                   
includes             O                    O                   
drug                 O                    O                   
eruption             O                    O                   
from                 O                    O                   
recent               O                    O                   
initiation           O                    O                   
of                   O                    O                   
gabapentin           B-MEDICATION         B-MEDICATION        
versus               O                    O                   
cutanous             O                    O                   
manifestation        O                    O                   
of                   O                    O                   
underlying           O                    O                   
stroke               B-DISEASE            B-DISEASE           
.                    O                    O                   
Biopsy               O                    O                   
performed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 12:
[CLS]                O                    O                   
Discharge            O                    O                   
Summary              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
was                  O                    O                   
admitted             O                    O                   
for                  O                    O                   
an                   O                    O                   
acute                O                    O                   
exacerbation         O                    O                   
of                   O                    O                   
lupus                B-DISEASE            O                   
.                    O                    O                   
During               O                    O                   
the                  O                    O                   
hospital             O                    O                   
stay                 O                    O                   
,                    O                    O                   
symptoms             O                    O                   
were                 O                    O                   
initially            O                    O                   
managed              O                    O                   
with                 O                    O                   
IV                   O                    O                   
fluids               O                    O                   
and                  O                    O                   
subsequently         O                    O                   
transitioned         O                    O                   
to                   O                    O                   
oral                 O                    O                   
gluten               B-MEDICATION         O                   
-                    I-MEDICATION         I-MEDICATION        
free                 I-MEDICATION         O                   
diet                 I-MEDICATION         O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
is                   O                    O                   
stable               O                    O                   
for                  O                    O                   
discharge            O                    O                   
and                  O                    O                   
instructed           O                    O                   
to                   O                    O                   
follow               O                    O                   
up                   O                    O                   
with                 O                    O                   
primary              O                    O                   
care                 O                    O                   
for                  O                    O                   
monitoring           O                    O                   
of                   O                    O                   
lupus                B-DISEASE            O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 13:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
sleep                B-DISEASE            B-DISEASE           
apnea                I-DISEASE            I-DISEASE           
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
xarelto              B-MEDICATION         B-MEDICATION        
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
sleep                B-DISEASE            B-DISEASE           
apnea                I-DISEASE            I-DISEASE           
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 14:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
gabapentin           B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
meningitis           B-DISEASE            B-DISEASE           
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
gabapentin           B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 15:
[CLS]                O                    O                   
The                  O                    O                   
62                   O                    O                   
-                    O                    O                   
year                 O                    O                   
-                    O                    O                   
old                  O                    O                   
female               O                    O                   
patient              O                    O                   
with                 O                    O                   
a                    O                    O                   
history              O                    O                   
of                   O                    O                   
migraine             B-DISEASE            B-DISEASE           
returns              O                    O                   
for                  O                    O                   
routine              O                    O                   
follow               O                    O                   
-                    O                    O                   
up                   O                    O                   
.                    O                    O                   
She                  O                    O                   
states               O                    O                   
that                 O                    O                   
the                  O                    O                   
isoniazid            B-MEDICATION         B-MEDICATION        
prescribed           O                    O                   
at                   O                    O                   
the                  O                    O                   
last                 O                    O                   
visit                O                    O                   
has                  O                    O                   
significantly        O                    O                   
reduced              O                    O                   
her                  O                    O                   
pain                 O                    O                   
levels               O                    O                   
.                    O                    O                   
However              O                    O                   
,                    O                    O                   
she                  O                    O                   
is                   O                    O                   
concerned            O                    O                   
about                O                    O                   
potential            O                    O                   
long                 O                    O                   
-                    O                    O                   
term                 O                    O                   
interactions         O                    O                   
between              O                    O                   
isoniazid            B-MEDICATION         B-MEDICATION        
and                  O                    O                   
her                  O                    O                   
other                O                    O                   
supplements          O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 16:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
sleep                B-DISEASE            B-DISEASE           
apnea                I-DISEASE            I-DISEASE           
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
methotrexate         B-MEDICATION         B-MEDICATION        
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
sleep                B-DISEASE            B-DISEASE           
apnea                I-DISEASE            I-DISEASE           
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 17:
[CLS]                O                    O                   
The                  O                    O                   
62                   O                    O                   
-                    O                    O                   
year                 O                    O                   
-                    O                    O                   
old                  O                    O                   
female               O                    O                   
patient              O                    O                   
with                 O                    O                   
a                    O                    O                   
history              O                    O                   
of                   O                    O                   
tuberculosis         B-DISEASE            O                   
returns              O                    O                   
for                  O                    O                   
routine              O                    O                   
follow               O                    O                   
-                    O                    O                   
up                   O                    O                   
.                    O                    O                   
She                  O                    O                   
states               O                    O                   
that                 O                    O                   
the                  O                    O                   
carbamazepine        B-MEDICATION         B-MEDICATION        
prescribed           O                    O                   
at                   O                    O                   
the                  O                    O                   
last                 O                    O                   
visit                O                    O                   
has                  O                    O                   
significantly        O                    O                   
reduced              O                    O                   
her                  O                    O                   
pain                 O                    O                   
levels               O                    O                   
.                    O                    O                   
However              O                    O                   
,                    O                    O                   
she                  O                    O                   
is                   O                    O                   
concerned            O                    O                   
about                O                    O                   
potential            O                    O                   
long                 O                    O                   
-                    O                    O                   
term                 O                    O                   
interactions         O                    O                   
between              O                    O                   
carbamazepine        B-MEDICATION         B-MEDICATION        
and                  O                    O                   
her                  O                    O                   
other                O                    O                   
supplements          O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 18:
[CLS]                O                    O                   
Emergent             O                    O                   
care                 O                    O                   
note                 O                    O                   
:                    O                    O                   
Patient              O                    O                   
found                O                    O                   
unresponsive         O                    O                   
.                    O                    O                   
Medical              O                    O                   
alert                O                    O                   
bracelet             O                    O                   
indicates            O                    O                   
diverticulitis       B-DISEASE            B-DISEASE           
.                    O                    O                   
EMS                  O                    O                   
administered         O                    O                   
naloxone             O                    O                   
without              O                    O                   
effect               O                    O                   
.                    O                    O                   
Family               O                    O                   
arrived              O                    O                   
and                  O                    O                   
confirmed            O                    O                   
patient              O                    O                   
takes                O                    O                   
metoprolol           B-MEDICATION         B-MEDICATION        
for                  O                    O                   
the                  O                    O                   
condition            O                    O                   
.                    O                    O                   
Transported          O                    O                   
to                   O                    O                   
ICU                  O                    O                   
for                  O                    O                   
further              O                    O                   
management           O                    O                   
of                   O                    O                   
status               O                    O                   
epilepticus          O                    O                   
secondary            O                    O                   
to                   O                    O                   
diverticulitis       B-DISEASE            B-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 19:
[CLS]                O                    O                   
Discharge            O                    O                   
Summary              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
was                  O                    O                   
admitted             O                    O                   
for                  O                    O                   
an                   O                    O                   
acute                O                    O                   
exacerbation         O                    O                   
of                   O                    O                   
fibromyalgia         B-DISEASE            B-DISEASE           
.                    O                    O                   
During               O                    O                   
the                  O                    O                   
hospital             O                    O                   
stay                 O                    O                   
,                    O                    O                   
symptoms             O                    O                   
were                 O                    O                   
initially            O                    O                   
managed              O                    O                   
with                 O                    O                   
IV                   O                    O                   
fluids               O                    O                   
and                  O                    O                   
subsequently         O                    O                   
transitioned         O                    O                   
to                   O                    O                   
oral                 O                    O                   
fluoxetine           B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
is                   O                    O                   
stable               O                    O                   
for                  O                    O                   
discharge            O                    O                   
and                  O                    O                   
instructed           O                    O                   
to                   O                    O                   
follow               O                    O                   
up                   O                    O                   
with                 O                    O                   
primary              O                    O                   
care                 O                    O                   
for                  O                    O                   
monitoring           O                    O                   
of                   O                    O                   
fibromyalgia         B-DISEASE            B-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 20:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
diverticulitis       B-DISEASE            B-DISEASE           
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
isoniazid            B-MEDICATION         B-MEDICATION        
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
diverticulitis       B-DISEASE            B-DISEASE           
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 21:
[CLS]                O                    O                   
Radiology            O                    O                   
Report               O                    O                   
:                    O                    O                   
Chest                O                    O                   
X                    O                    O                   
-                    O                    O                   
ray                  O                    O                   
shows                O                    O                   
patchy               O                    O                   
infiltrates          O                    O                   
consistent           O                    O                   
with                 O                    O                   
tuberculosis         B-DISEASE            O                   
.                    O                    O                   
Clinical             O                    O                   
correlation          O                    O                   
is                   O                    O                   
recommended          O                    O                   
.                    O                    O                   
Given                O                    O                   
the                  O                    O                   
imaging              O                    O                   
findings             O                    O                   
and                  O                    O                   
clinical             O                    O                   
presentation         O                    O                   
,                    O                    O                   
empiric              O                    O                   
treatment            O                    O                   
with                 O                    O                   
sertraline           B-MEDICATION         B-MEDICATION        
should               O                    O                   
be                   O                    O                   
considered           O                    O                   
pending              O                    O                   
culture              O                    O                   
results              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 22:
[CLS]                O                    O                   
The                  O                    O                   
patient              O                    O                   
,                    O                    O                   
a                    O                    O                   
45                   O                    O                   
-                    O                    O                   
year                 O                    O                   
-                    O                    O                   
old                  O                    O                   
male                 O                    O                   
with                 O                    O                   
a                    O                    O                   
significant          O                    O                   
past                 O                    O                   
medical              O                    O                   
history              O                    O                   
of                   O                    O                   
sarcoidosis          B-DISEASE            B-DISEASE           
,                    O                    O                   
presented            O                    O                   
to                   O                    O                   
the                  O                    O                   
emergency            O                    O                   
department           O                    O                   
complaining          O                    O                   
of                   O                    O                   
worsening            O                    O                   
fatigue              O                    O                   
and                  O                    O                   
shortness            O                    O                   
of                   O                    O                   
breath               O                    O                   
.                    O                    O                   
Upon                 O                    O                   
review               O                    O                   
of                   O                    O                   
systems              O                    O                   
,                    O                    O                   
he                   O                    O                   
noted                O                    O                   
that                 O                    O                   
he                   O                    O                   
has                  O                    O                   
been                 O                    O                   
non                  O                    O                   
-                    O                    O                   
compliant            O                    O                   
with                 O                    O                   
his                  O                    O                   
home                 O                    O                   
medication           O                    O                   
,                    O                    O                   
carbamazepine        B-MEDICATION         B-MEDICATION        
,                    O                    O                   
for                  O                    O                   
the                  O                    O                   
past                 O                    O                   
two                  O                    O                   
weeks                O                    O                   
due                  O                    O                   
to                   O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 23:
[CLS]                O                    O                   
The                  O                    O                   
62                   O                    O                   
-                    O                    O                   
year                 O                    O                   
-                    O                    O                   
old                  O                    O                   
female               O                    O                   
patient              O                    O                   
with                 O                    O                   
a                    O                    O                   
history              O                    O                   
of                   O                    O                   
multiple             B-DISEASE            B-DISEASE           
sclerosis            I-DISEASE            I-DISEASE           
returns              O                    O                   
for                  O                    O                   
routine              O                    O                   
follow               O                    O                   
-                    O                    O                   
up                   O                    O                   
.                    O                    O                   
She                  O                    O                   
states               O                    O                   
that                 O                    O                   
the                  O                    O                   
sertraline           B-MEDICATION         B-MEDICATION        
prescribed           O                    O                   
at                   O                    O                   
the                  O                    O                   
last                 O                    O                   
visit                O                    O                   
has                  O                    O                   
significantly        O                    O                   
reduced              O                    O                   
her                  O                    O                   
pain                 O                    O                   
levels               O                    O                   
.                    O                    O                   
However              O                    O                   
,                    O                    O                   
she                  O                    O                   
is                   O                    O                   
concerned            O                    O                   
about                O                    O                   
potential            O                    O                   
long                 O                    O                   
-                    O                    O                   
term                 O                    O                   
interactions         O                    O                   
between              O                    O                   
sertraline           B-MEDICATION         B-MEDICATION        
and                  O                    O                   
her                  O                    O                   
other                O                    O                   
supplements          O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 24:
[CLS]                O                    O                   
Emergent             O                    O                   
care                 O                    O                   
note                 O                    O                   
:                    O                    O                   
Patient              O                    O                   
found                O                    O                   
unresponsive         O                    O                   
.                    O                    O                   
Medical              O                    O                   
alert                O                    O                   
bracelet             O                    O                   
indicates            O                    O                   
irritable            B-DISEASE            O                   
bowel                I-DISEASE            O                   
syndrome             I-DISEASE            O                   
.                    O                    O                   
EMS                  O                    O                   
administered         O                    O                   
naloxone             O                    O                   
without              O                    O                   
effect               O                    O                   
.                    O                    O                   
Family               O                    O                   
arrived              O                    O                   
and                  O                    O                   
confirmed            O                    O                   
patient              O                    O                   
takes                O                    O                   
sumatriptan          B-MEDICATION         B-MEDICATION        
for                  O                    O                   
the                  O                    O                   
condition            O                    O                   
.                    O                    O                   
Transported          O                    O                   
to                   O                    O                   
ICU                  O                    O                   
for                  O                    O                   
further              O                    O                   
management           O                    O                   
of                   O                    O                   
status               O                    O                   
epilepticus          O                    O                   
secondary            O                    O                   
to                   O                    O                   
irritable            B-DISEASE            O                   
bowel                I-DISEASE            O                   
syndrome             I-DISEASE            O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 25:
[CLS]                O                    O                   
Assessment           O                    O                   
and                  O                    O                   
Plan                 O                    O                   
:                    O                    O                   
#                    O                    O                   
osteoporosis         B-DISEASE            B-DISEASE           
-                    O                    O                   
largely              O                    O                   
controlled           O                    O                   
but                  O                    O                   
recent               O                    O                   
stress               O                    O                   
has                  O                    O                   
caused               O                    O                   
an                   O                    O                   
uptick               O                    O                   
in                   O                    O                   
symptoms             O                    O                   
.                    O                    O                   
We                   O                    O                   
will                 O                    O                   
increase             O                    O                   
the                  O                    O                   
dosage               O                    O                   
of                   O                    O                   
bupropion            B-MEDICATION         B-MEDICATION        
from                 O                    O                   
10mg                 O                    O                   
to                   O                    O                   
20mg                 O                    O                   
daily                O                    O                   
.                    O                    O                   
Patient              O                    O                   
was                  O                    O                   
advised              O                    O                   
to                   O                    O                   
monitor              O                    O                   
for                  O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
#                    O                    O                   
Hypertension         O                    O                   
-                    O                    O                   
stable               O                    O                   
.                    O                    O                   
#                    O                    O                   
Diabetes             O                    O                   
-                    O                    O                   
diet                 O                    O                   
controlled           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 26:
[CLS]                O                    O                   
Assessment           O                    O                   
and                  O                    O                   
Plan                 O                    O                   
:                    O                    O                   
#                    O                    O                   
vertigo              B-DISEASE            B-DISEASE           
-                    O                    O                   
largely              O                    O                   
controlled           O                    O                   
but                  O                    O                   
recent               O                    O                   
stress               O                    O                   
has                  O                    O                   
caused               O                    O                   
an                   O                    O                   
uptick               O                    O                   
in                   O                    O                   
symptoms             O                    O                   
.                    O                    O                   
We                   O                    O                   
will                 O                    O                   
increase             O                    O                   
the                  O                    O                   
dosage               O                    O                   
of                   O                    O                   
omeprazole           B-MEDICATION         B-MEDICATION        
from                 O                    O                   
10mg                 O                    O                   
to                   O                    O                   
20mg                 O                    O                   
daily                O                    O                   
.                    O                    O                   
Patient              O                    O                   
was                  O                    O                   
advised              O                    O                   
to                   O                    O                   
monitor              O                    O                   
for                  O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
#                    O                    O                   
Hypertension         O                    O                   
-                    O                    O                   
stable               O                    O                   
.                    O                    O                   
#                    O                    O                   
Diabetes             O                    O                   
-                    O                    O                   
diet                 O                    O                   
controlled           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 27:
[CLS]                O                    O                   
Assessment           O                    O                   
and                  O                    O                   
Plan                 O                    O                   
:                    O                    O                   
#                    O                    O                   
atrial               B-DISEASE            B-DISEASE           
fibrillation         I-DISEASE            I-DISEASE           
-                    O                    O                   
largely              O                    O                   
controlled           O                    O                   
but                  O                    O                   
recent               O                    O                   
stress               O                    O                   
has                  O                    O                   
caused               O                    O                   
an                   O                    O                   
uptick               O                    O                   
in                   O                    O                   
symptoms             O                    O                   
.                    O                    O                   
We                   O                    O                   
will                 O                    O                   
increase             O                    O                   
the                  O                    O                   
dosage               O                    O                   
of                   O                    O                   
eliquis              B-MEDICATION         B-MEDICATION        
from                 O                    O                   
10mg                 O                    O                   
to                   O                    O                   
20mg                 O                    O                   
daily                O                    O                   
.                    O                    O                   
Patient              O                    O                   
was                  O                    O                   
advised              O                    O                   
to                   O                    O                   
monitor              O                    O                   
for                  O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
#                    O                    O                   
Hypertension         O                    O                   
-                    O                    O                   
stable               O                    O                   
.                    O                    O                   
#                    O                    O                   
Diabetes             O                    O                   
-                    O                    O                   
diet                 O                    O                   
controlled           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 28:
[CLS]                O                    O                   
Discharge            O                    O                   
Summary              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
was                  O                    O                   
admitted             O                    O                   
for                  O                    O                   
an                   O                    O                   
acute                O                    O                   
exacerbation         O                    O                   
of                   O                    O                   
alzheimer            B-DISEASE            B-DISEASE           
'                    I-DISEASE            I-DISEASE           
s                    I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
During               O                    O                   
the                  O                    O                   
hospital             O                    O                   
stay                 O                    O                   
,                    O                    O                   
symptoms             O                    O                   
were                 O                    O                   
initially            O                    O                   
managed              O                    O                   
with                 O                    O                   
IV                   O                    O                   
fluids               O                    O                   
and                  O                    O                   
subsequently         O                    O                   
transitioned         O                    O                   
to                   O                    O                   
oral                 O                    O                   
bupropion            B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
is                   O                    O                   
stable               O                    O                   
for                  O                    O                   
discharge            O                    O                   
and                  O                    O                   
instructed           O                    O                   
to                   O                    O                   
follow               O                    O                   
up                   O                    O                   
with                 O                    O                   
primary              O                    O                   
care                 O                    O                   
for                  O                    O                   
monitoring           O                    O                   
of                   O                    O                   
alzheimer            B-DISEASE            B-DISEASE           
'                    I-DISEASE            I-DISEASE           
s                    I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 29:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
methotrexate         B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
multiple             B-DISEASE            B-DISEASE           
sclerosis            I-DISEASE            I-DISEASE           
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
methotrexate         B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 30:
[CLS]                O                    O                   
Discharge            O                    O                   
Summary              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
was                  O                    O                   
admitted             O                    O                   
for                  O                    O                   
an                   O                    O                   
acute                O                    O                   
exacerbation         O                    O                   
of                   O                    O                   
fibromyalgia         B-DISEASE            B-DISEASE           
.                    O                    O                   
During               O                    O                   
the                  O                    O                   
hospital             O                    O                   
stay                 O                    O                   
,                    O                    O                   
symptoms             O                    O                   
were                 O                    O                   
initially            O                    O                   
managed              O                    O                   
with                 O                    O                   
IV                   O                    O                   
fluids               O                    O                   
and                  O                    O                   
subsequently         O                    O                   
transitioned         O                    O                   
to                   O                    O                   
oral                 O                    O                   
dexamethasone        B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
is                   O                    O                   
stable               O                    O                   
for                  O                    O                   
discharge            O                    O                   
and                  O                    O                   
instructed           O                    O                   
to                   O                    O                   
follow               O                    O                   
up                   O                    O                   
with                 O                    O                   
primary              O                    O                   
care                 O                    O                   
for                  O                    O                   
monitoring           O                    O                   
of                   O                    O                   
fibromyalgia         B-DISEASE            B-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 31:
[CLS]                O                    O                   
Radiology            O                    O                   
Report               O                    O                   
:                    O                    O                   
Chest                O                    O                   
X                    O                    O                   
-                    O                    O                   
ray                  O                    O                   
shows                O                    O                   
patchy               O                    O                   
infiltrates          O                    O                   
consistent           O                    O                   
with                 O                    O                   
sarcoidosis          B-DISEASE            B-DISEASE           
.                    O                    O                   
Clinical             O                    O                   
correlation          O                    O                   
is                   O                    O                   
recommended          O                    O                   
.                    O                    O                   
Given                O                    O                   
the                  O                    O                   
imaging              O                    O                   
findings             O                    O                   
and                  O                    O                   
clinical             O                    O                   
presentation         O                    O                   
,                    O                    O                   
empiric              O                    O                   
treatment            O                    O                   
with                 O                    O                   
eliquis              B-MEDICATION         B-MEDICATION        
should               O                    O                   
be                   O                    O                   
considered           O                    O                   
pending              O                    O                   
culture              O                    O                   
results              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 32:
[CLS]                O                    O                   
The                  O                    O                   
patient              O                    O                   
,                    O                    O                   
a                    O                    O                   
45                   O                    O                   
-                    O                    O                   
year                 O                    O                   
-                    O                    O                   
old                  O                    O                   
male                 O                    O                   
with                 O                    O                   
a                    O                    O                   
significant          O                    O                   
past                 O                    O                   
medical              O                    O                   
history              O                    O                   
of                   O                    O                   
epilepsy             B-DISEASE            B-DISEASE           
,                    O                    O                   
presented            O                    O                   
to                   O                    O                   
the                  O                    O                   
emergency            O                    O                   
department           O                    O                   
complaining          O                    O                   
of                   O                    O                   
worsening            O                    O                   
fatigue              O                    O                   
and                  O                    O                   
shortness            O                    O                   
of                   O                    O                   
breath               O                    O                   
.                    O                    O                   
Upon                 O                    O                   
review               O                    O                   
of                   O                    O                   
systems              O                    O                   
,                    O                    O                   
he                   O                    O                   
noted                O                    O                   
that                 O                    O                   
he                   O                    O                   
has                  O                    O                   
been                 O                    O                   
non                  O                    O                   
-                    O                    O                   
compliant            O                    O                   
with                 O                    O                   
his                  O                    O                   
home                 O                    O                   
medication           O                    O                   
,                    O                    O                   
gabapentin           B-MEDICATION         B-MEDICATION        
,                    O                    O                   
for                  O                    O                   
the                  O                    O                   
past                 O                    O                   
two                  O                    O                   
weeks                O                    O                   
due                  O                    O                   
to                   O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 33:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
omeprazole           B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
osteoporosis         B-DISEASE            B-DISEASE           
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
omeprazole           B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 34:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
fluoxetine           B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
fibromyalgia         B-DISEASE            B-DISEASE           
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
fluoxetine           B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 35:
[CLS]                O                    O                   
Subjective           O                    O                   
:                    O                    O                   
Patient              O                    O                   
reports              O                    O                   
feeling              O                    O                   
'                    O                    O                   
unwell               O                    O                   
'                    O                    O                   
for                  O                    O                   
3                    O                    O                   
days                 O                    O                   
.                    O                    O                   
History              O                    O                   
of                   O                    O                   
present              O                    O                   
illness              O                    O                   
is                   O                    O                   
consistent           O                    O                   
with                 O                    O                   
a                    O                    O                   
flare                O                    O                   
of                   O                    O                   
lupus                B-DISEASE            O                   
.                    O                    O                   
She                  O                    O                   
mentions             O                    O                   
she                  O                    O                   
ran                  O                    O                   
out                  O                    O                   
of                   O                    O                   
ciprofloxacin        B-MEDICATION         B-MEDICATION        
4                    O                    O                   
days                 O                    O                   
ago                  O                    O                   
.                    O                    O                   
Objective            O                    O                   
:                    O                    O                   
Vitals               O                    O                   
stable               O                    O                   
.                    O                    O                   
Plan                 O                    O                   
:                    O                    O                   
Restart              O                    O                   
ciprofloxacin        B-MEDICATION         B-MEDICATION        
immediately          O                    O                   
and                  O                    O                   
schedule             O                    O                   
lab                  O                    O                   
work                 O                    O                   
to                   O                    O                   
assess               O                    O                   
specificity          O                    O                   
of                   O                    O                   
lupus                B-DISEASE            O                   
markers              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 36:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
eliquis              B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
hepatitis            B-DISEASE            B-DISEASE           
b                    I-DISEASE            O                   
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
eliquis              B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 37:
[CLS]                O                    O                   
Discharge            O                    O                   
Summary              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
was                  O                    O                   
admitted             O                    O                   
for                  O                    O                   
an                   O                    O                   
acute                O                    O                   
exacerbation         O                    O                   
of                   O                    O                   
celiac               B-DISEASE            B-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
During               O                    O                   
the                  O                    O                   
hospital             O                    O                   
stay                 O                    O                   
,                    O                    O                   
symptoms             O                    O                   
were                 O                    O                   
initially            O                    O                   
managed              O                    O                   
with                 O                    O                   
IV                   O                    O                   
fluids               O                    O                   
and                  O                    O                   
subsequently         O                    O                   
transitioned         O                    O                   
to                   O                    O                   
oral                 O                    O                   
fluoxetine           B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
is                   O                    O                   
stable               O                    O                   
for                  O                    O                   
discharge            O                    O                   
and                  O                    O                   
instructed           O                    O                   
to                   O                    O                   
follow               O                    O                   
up                   O                    O                   
with                 O                    O                   
primary              O                    O                   
care                 O                    O                   
for                  O                    O                   
monitoring           O                    O                   
of                   O                    O                   
celiac               B-DISEASE            B-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 38:
[CLS]                O                    O                   
Dermatology          O                    O                   
consult              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
presents             O                    O                   
with                 O                    O                   
a                    O                    O                   
diffuse              O                    O                   
rash                 O                    O                   
.                    O                    O                   
Differential         O                    O                   
diagnosis            O                    O                   
includes             O                    O                   
drug                 O                    O                   
eruption             O                    O                   
from                 O                    O                   
recent               O                    O                   
initiation           O                    O                   
of                   O                    O                   
gluten               B-MEDICATION         O                   
-                    I-MEDICATION         I-MEDICATION        
free                 I-MEDICATION         O                   
diet                 I-MEDICATION         O                   
versus               O                    O                   
cutanous             O                    O                   
manifestation        O                    O                   
of                   O                    O                   
underlying           O                    O                   
colon                B-DISEASE            B-DISEASE           
cancer               I-DISEASE            I-DISEASE           
.                    O                    O                   
Biopsy               O                    O                   
performed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 39:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
multiple             B-DISEASE            B-DISEASE           
sclerosis            I-DISEASE            I-DISEASE           
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
bupropion            B-MEDICATION         B-MEDICATION        
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
multiple             B-DISEASE            B-DISEASE           
sclerosis            I-DISEASE            I-DISEASE           
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 40:
[CLS]                O                    O                   
Discharge            O                    O                   
Summary              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
was                  O                    O                   
admitted             O                    O                   
for                  O                    O                   
an                   O                    O                   
acute                O                    O                   
exacerbation         O                    O                   
of                   O                    O                   
migraine             B-DISEASE            B-DISEASE           
.                    O                    O                   
During               O                    O                   
the                  O                    O                   
hospital             O                    O                   
stay                 O                    O                   
,                    O                    O                   
symptoms             O                    O                   
were                 O                    O                   
initially            O                    O                   
managed              O                    O                   
with                 O                    O                   
IV                   O                    O                   
fluids               O                    O                   
and                  O                    O                   
subsequently         O                    O                   
transitioned         O                    O                   
to                   O                    O                   
oral                 O                    O                   
omeprazole           B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
is                   O                    O                   
stable               O                    O                   
for                  O                    O                   
discharge            O                    O                   
and                  O                    O                   
instructed           O                    O                   
to                   O                    O                   
follow               O                    O                   
up                   O                    O                   
with                 O                    O                   
primary              O                    O                   
care                 O                    O                   
for                  O                    O                   
monitoring           O                    O                   
of                   O                    O                   
migraine             B-DISEASE            B-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 41:
[CLS]                O                    O                   
Radiology            O                    O                   
Report               O                    O                   
:                    O                    O                   
Chest                O                    O                   
X                    O                    O                   
-                    O                    O                   
ray                  O                    O                   
shows                O                    O                   
patchy               O                    O                   
infiltrates          O                    O                   
consistent           O                    O                   
with                 O                    O                   
fibromyalgia         B-DISEASE            B-DISEASE           
.                    O                    O                   
Clinical             O                    O                   
correlation          O                    O                   
is                   O                    O                   
recommended          O                    O                   
.                    O                    O                   
Given                O                    O                   
the                  O                    O                   
imaging              O                    O                   
findings             O                    O                   
and                  O                    O                   
clinical             O                    O                   
presentation         O                    O                   
,                    O                    O                   
empiric              O                    O                   
treatment            O                    O                   
with                 O                    O                   
eliquis              B-MEDICATION         B-MEDICATION        
should               O                    O                   
be                   O                    O                   
considered           O                    O                   
pending              O                    O                   
culture              O                    O                   
results              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 42:
[CLS]                O                    O                   
Radiology            O                    O                   
Report               O                    O                   
:                    O                    O                   
Chest                O                    O                   
X                    O                    O                   
-                    O                    O                   
ray                  O                    O                   
shows                O                    O                   
patchy               O                    O                   
infiltrates          O                    O                   
consistent           O                    O                   
with                 O                    O                   
sleep                B-DISEASE            B-DISEASE           
apnea                I-DISEASE            I-DISEASE           
.                    O                    O                   
Clinical             O                    O                   
correlation          O                    O                   
is                   O                    O                   
recommended          O                    O                   
.                    O                    O                   
Given                O                    O                   
the                  O                    O                   
imaging              O                    O                   
findings             O                    O                   
and                  O                    O                   
clinical             O                    O                   
presentation         O                    O                   
,                    O                    O                   
empiric              O                    O                   
treatment            O                    O                   
with                 O                    O                   
bupropion            B-MEDICATION         B-MEDICATION        
should               O                    O                   
be                   O                    O                   
considered           O                    O                   
pending              O                    O                   
culture              O                    O                   
results              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 43:
[CLS]                O                    O                   
The                  O                    O                   
62                   O                    O                   
-                    O                    O                   
year                 O                    O                   
-                    O                    O                   
old                  O                    O                   
female               O                    O                   
patient              O                    O                   
with                 O                    O                   
a                    O                    O                   
history              O                    O                   
of                   O                    O                   
sleep                B-DISEASE            B-DISEASE           
apnea                I-DISEASE            I-DISEASE           
returns              O                    O                   
for                  O                    O                   
routine              O                    O                   
follow               O                    O                   
-                    O                    O                   
up                   O                    O                   
.                    O                    O                   
She                  O                    O                   
states               O                    O                   
that                 O                    O                   
the                  O                    O                   
gabapentin           B-MEDICATION         B-MEDICATION        
prescribed           O                    O                   
at                   O                    O                   
the                  O                    O                   
last                 O                    O                   
visit                O                    O                   
has                  O                    O                   
significantly        O                    O                   
reduced              O                    O                   
her                  O                    O                   
pain                 O                    O                   
levels               O                    O                   
.                    O                    O                   
However              O                    O                   
,                    O                    O                   
she                  O                    O                   
is                   O                    O                   
concerned            O                    O                   
about                O                    O                   
potential            O                    O                   
long                 O                    O                   
-                    O                    O                   
term                 O                    O                   
interactions         O                    O                   
between              O                    O                   
gabapentin           B-MEDICATION         B-MEDICATION        
and                  O                    O                   
her                  O                    O                   
other                O                    O                   
supplements          O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 44:
[CLS]                O                    O                   
Dermatology          O                    O                   
consult              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
presents             O                    O                   
with                 O                    O                   
a                    O                    O                   
diffuse              O                    O                   
rash                 O                    O                   
.                    O                    O                   
Differential         O                    O                   
diagnosis            O                    O                   
includes             O                    O                   
drug                 O                    O                   
eruption             O                    O                   
from                 O                    O                   
recent               O                    O                   
initiation           O                    O                   
of                   O                    O                   
atorvastatin         B-MEDICATION         B-MEDICATION        
versus               O                    O                   
cutanous             O                    O                   
manifestation        O                    O                   
of                   O                    O                   
underlying           O                    O                   
sarcoidosis          B-DISEASE            B-DISEASE           
.                    O                    O                   
Biopsy               O                    O                   
performed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 45:
[CLS]                O                    O                   
Subjective           O                    O                   
:                    O                    O                   
Patient              O                    O                   
reports              O                    O                   
feeling              O                    O                   
'                    O                    O                   
unwell               O                    O                   
'                    O                    O                   
for                  O                    O                   
3                    O                    O                   
days                 O                    O                   
.                    O                    O                   
History              O                    O                   
of                   O                    O                   
present              O                    O                   
illness              O                    O                   
is                   O                    O                   
consistent           O                    O                   
with                 O                    O                   
a                    O                    O                   
flare                O                    O                   
of                   O                    O                   
celiac               B-DISEASE            B-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
She                  O                    O                   
mentions             O                    O                   
she                  O                    O                   
ran                  O                    O                   
out                  O                    O                   
of                   O                    O                   
isoniazid            B-MEDICATION         B-MEDICATION        
4                    O                    O                   
days                 O                    O                   
ago                  O                    O                   
.                    O                    O                   
Objective            O                    O                   
:                    O                    O                   
Vitals               O                    O                   
stable               O                    O                   
.                    O                    O                   
Plan                 O                    O                   
:                    O                    O                   
Restart              O                    O                   
isoniazid            B-MEDICATION         B-MEDICATION        
immediately          O                    O                   
and                  O                    O                   
schedule             O                    O                   
lab                  O                    O                   
work                 O                    O                   
to                   O                    O                   
assess               O                    O                   
specificity          O                    O                   
of                   O                    O                   
celiac               B-DISEASE            B-DISEASE           
disease              I-DISEASE            I-DISEASE           
markers              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 46:
[CLS]                O                    O                   
Assessment           O                    O                   
and                  O                    O                   
Plan                 O                    O                   
:                    O                    O                   
#                    O                    O                   
vertigo              B-DISEASE            B-DISEASE           
-                    O                    O                   
largely              O                    O                   
controlled           O                    O                   
but                  O                    O                   
recent               O                    O                   
stress               O                    O                   
has                  O                    O                   
caused               O                    O                   
an                   O                    O                   
uptick               O                    O                   
in                   O                    O                   
symptoms             O                    O                   
.                    O                    O                   
We                   O                    O                   
will                 O                    O                   
increase             O                    O                   
the                  O                    O                   
dosage               O                    O                   
of                   O                    O                   
hydroxychloroquine   B-MEDICATION         B-MEDICATION        
from                 O                    O                   
10mg                 O                    O                   
to                   O                    O                   
20mg                 O                    O                   
daily                O                    O                   
.                    O                    O                   
Patient              O                    O                   
was                  O                    O                   
advised              O                    O                   
to                   O                    O                   
monitor              O                    O                   
for                  O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
#                    O                    O                   
Hypertension         O                    O                   
-                    O                    O                   
stable               O                    O                   
.                    O                    O                   
#                    O                    O                   
Diabetes             O                    O                   
-                    O                    O                   
diet                 O                    O                   
controlled           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 47:
[CLS]                O                    O                   
Discharge            O                    O                   
Summary              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
was                  O                    O                   
admitted             O                    O                   
for                  O                    O                   
an                   O                    O                   
acute                O                    O                   
exacerbation         O                    O                   
of                   O                    O                   
multiple             B-DISEASE            B-DISEASE           
sclerosis            I-DISEASE            I-DISEASE           
.                    O                    O                   
During               O                    O                   
the                  O                    O                   
hospital             O                    O                   
stay                 O                    O                   
,                    O                    O                   
symptoms             O                    O                   
were                 O                    O                   
initially            O                    O                   
managed              O                    O                   
with                 O                    O                   
IV                   O                    O                   
fluids               O                    O                   
and                  O                    O                   
subsequently         O                    O                   
transitioned         O                    O                   
to                   O                    O                   
oral                 O                    O                   
methotrexate         B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
is                   O                    O                   
stable               O                    O                   
for                  O                    O                   
discharge            O                    O                   
and                  O                    O                   
instructed           O                    O                   
to                   O                    O                   
follow               O                    O                   
up                   O                    O                   
with                 O                    O                   
primary              O                    O                   
care                 O                    O                   
for                  O                    O                   
monitoring           O                    O                   
of                   O                    O                   
multiple             B-DISEASE            B-DISEASE           
sclerosis            I-DISEASE            I-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 48:
[CLS]                O                    O                   
Discharge            O                    O                   
Summary              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
was                  O                    O                   
admitted             O                    O                   
for                  O                    O                   
an                   O                    O                   
acute                O                    O                   
exacerbation         O                    O                   
of                   O                    O                   
melanoma             B-DISEASE            B-DISEASE           
.                    O                    O                   
During               O                    O                   
the                  O                    O                   
hospital             O                    O                   
stay                 O                    O                   
,                    O                    O                   
symptoms             O                    O                   
were                 O                    O                   
initially            O                    O                   
managed              O                    O                   
with                 O                    O                   
IV                   O                    O                   
fluids               O                    O                   
and                  O                    O                   
subsequently         O                    O                   
transitioned         O                    O                   
to                   O                    O                   
oral                 O                    O                   
dexamethasone        B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
is                   O                    O                   
stable               O                    O                   
for                  O                    O                   
discharge            O                    O                   
and                  O                    O                   
instructed           O                    O                   
to                   O                    O                   
follow               O                    O                   
up                   O                    O                   
with                 O                    O                   
primary              O                    O                   
care                 O                    O                   
for                  O                    O                   
monitoring           O                    O                   
of                   O                    O                   
melanoma             B-DISEASE            B-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 49:
[CLS]                O                    O                   
The                  O                    O                   
patient              O                    O                   
,                    O                    O                   
a                    O                    O                   
45                   O                    O                   
-                    O                    O                   
year                 O                    O                   
-                    O                    O                   
old                  O                    O                   
male                 O                    O                   
with                 O                    O                   
a                    O                    O                   
significant          O                    O                   
past                 O                    O                   
medical              O                    O                   
history              O                    O                   
of                   O                    O                   
melanoma             B-DISEASE            B-DISEASE           
,                    O                    O                   
presented            O                    O                   
to                   O                    O                   
the                  O                    O                   
emergency            O                    O                   
department           O                    O                   
complaining          O                    O                   
of                   O                    O                   
worsening            O                    O                   
fatigue              O                    O                   
and                  O                    O                   
shortness            O                    O                   
of                   O                    O                   
breath               O                    O                   
.                    O                    O                   
Upon                 O                    O                   
review               O                    O                   
of                   O                    O                   
systems              O                    O                   
,                    O                    O                   
he                   O                    O                   
noted                O                    O                   
that                 O                    O                   
he                   O                    O                   
has                  O                    O                   
been                 O                    O                   
non                  O                    O                   
-                    O                    O                   
compliant            O                    O                   
with                 O                    O                   
his                  O                    O                   
home                 O                    O                   
medication           O                    O                   
,                    O                    O                   
ibuprofen            B-MEDICATION         B-MEDICATION        
,                    O                    O                   
for                  O                    O                   
the                  O                    O                   
past                 O                    O                   
two                  O                    O                   
weeks                O                    O                   
due                  O                    O                   
to                   O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 50:
[CLS]                O                    O                   
The                  O                    O                   
62                   O                    O                   
-                    O                    O                   
year                 O                    O                   
-                    O                    O                   
old                  O                    O                   
female               O                    O                   
patient              O                    O                   
with                 O                    O                   
a                    O                    O                   
history              O                    O                   
of                   O                    O                   
hepatitis            B-DISEASE            B-DISEASE           
b                    I-DISEASE            O                   
returns              O                    O                   
for                  O                    O                   
routine              O                    O                   
follow               O                    O                   
-                    O                    O                   
up                   O                    O                   
.                    O                    O                   
She                  O                    O                   
states               O                    O                   
that                 O                    O                   
the                  O                    O                   
hydrochlorothiazide  B-MEDICATION         B-MEDICATION        
prescribed           O                    O                   
at                   O                    O                   
the                  O                    O                   
last                 O                    O                   
visit                O                    O                   
has                  O                    O                   
significantly        O                    O                   
reduced              O                    O                   
her                  O                    O                   
pain                 O                    O                   
levels               O                    O                   
.                    O                    O                   
However              O                    O                   
,                    O                    O                   
she                  O                    O                   
is                   O                    O                   
concerned            O                    O                   
about                O                    O                   
potential            O                    O                   
long                 O                    O                   
-                    O                    O                   
term                 O                    O                   
interactions         O                    O                   
between              O                    O                   
hydrochlorothiazide  B-MEDICATION         B-MEDICATION        
and                  O                    O                   
her                  O                    O                   
other                O                    O                   
supplements          O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 51:
[CLS]                O                    O                   
Assessment           O                    O                   
and                  O                    O                   
Plan                 O                    O                   
:                    O                    O                   
#                    O                    O                   
sleep                B-DISEASE            B-DISEASE           
apnea                I-DISEASE            I-DISEASE           
-                    O                    O                   
largely              O                    O                   
controlled           O                    O                   
but                  O                    O                   
recent               O                    O                   
stress               O                    O                   
has                  O                    O                   
caused               O                    O                   
an                   O                    O                   
uptick               O                    O                   
in                   O                    O                   
symptoms             O                    O                   
.                    O                    O                   
We                   O                    O                   
will                 O                    O                   
increase             O                    O                   
the                  O                    O                   
dosage               O                    O                   
of                   O                    O                   
isoniazid            B-MEDICATION         B-MEDICATION        
from                 O                    O                   
10mg                 O                    O                   
to                   O                    O                   
20mg                 O                    O                   
daily                O                    O                   
.                    O                    O                   
Patient              O                    O                   
was                  O                    O                   
advised              O                    O                   
to                   O                    O                   
monitor              O                    O                   
for                  O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
#                    O                    O                   
Hypertension         O                    O                   
-                    O                    O                   
stable               O                    O                   
.                    O                    O                   
#                    O                    O                   
Diabetes             O                    O                   
-                    O                    O                   
diet                 O                    O                   
controlled           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 52:
[CLS]                O                    O                   
Subjective           O                    O                   
:                    O                    O                   
Patient              O                    O                   
reports              O                    O                   
feeling              O                    O                   
'                    O                    O                   
unwell               O                    O                   
'                    O                    O                   
for                  O                    O                   
3                    O                    O                   
days                 O                    O                   
.                    O                    O                   
History              O                    O                   
of                   O                    O                   
present              O                    O                   
illness              O                    O                   
is                   O                    O                   
consistent           O                    O                   
with                 O                    O                   
a                    O                    O                   
flare                O                    O                   
of                   O                    O                   
diverticulitis       B-DISEASE            B-DISEASE           
.                    O                    O                   
She                  O                    O                   
mentions             O                    O                   
she                  O                    O                   
ran                  O                    O                   
out                  O                    O                   
of                   O                    O                   
gabapentin           B-MEDICATION         B-MEDICATION        
4                    O                    O                   
days                 O                    O                   
ago                  O                    O                   
.                    O                    O                   
Objective            O                    O                   
:                    O                    O                   
Vitals               O                    O                   
stable               O                    O                   
.                    O                    O                   
Plan                 O                    O                   
:                    O                    O                   
Restart              O                    O                   
gabapentin           B-MEDICATION         B-MEDICATION        
immediately          O                    O                   
and                  O                    O                   
schedule             O                    O                   
lab                  O                    O                   
work                 O                    O                   
to                   O                    O                   
assess               O                    O                   
specificity          O                    O                   
of                   O                    O                   
diverticulitis       B-DISEASE            B-DISEASE           
markers              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 53:
[CLS]                O                    O                   
Radiology            O                    O                   
Report               O                    O                   
:                    O                    O                   
Chest                O                    O                   
X                    O                    O                   
-                    O                    O                   
ray                  O                    O                   
shows                O                    O                   
patchy               O                    O                   
infiltrates          O                    O                   
consistent           O                    O                   
with                 O                    O                   
meningitis           B-DISEASE            B-DISEASE           
.                    O                    O                   
Clinical             O                    O                   
correlation          O                    O                   
is                   O                    O                   
recommended          O                    O                   
.                    O                    O                   
Given                O                    O                   
the                  O                    O                   
imaging              O                    O                   
findings             O                    O                   
and                  O                    O                   
clinical             O                    O                   
presentation         O                    O                   
,                    O                    O                   
empiric              O                    O                   
treatment            O                    O                   
with                 O                    O                   
albuterol            B-MEDICATION         O                   
should               O                    O                   
be                   O                    O                   
considered           O                    O                   
pending              O                    O                   
culture              O                    O                   
results              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 54:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
anemia               B-DISEASE            B-DISEASE           
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
morphine             B-MEDICATION         B-MEDICATION        
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
anemia               B-DISEASE            B-DISEASE           
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 55:
[CLS]                O                    O                   
Discharge            O                    O                   
Summary              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
was                  O                    O                   
admitted             O                    O                   
for                  O                    O                   
an                   O                    O                   
acute                O                    O                   
exacerbation         O                    O                   
of                   O                    O                   
alzheimer            B-DISEASE            B-DISEASE           
'                    I-DISEASE            I-DISEASE           
s                    I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
During               O                    O                   
the                  O                    O                   
hospital             O                    O                   
stay                 O                    O                   
,                    O                    O                   
symptoms             O                    O                   
were                 O                    O                   
initially            O                    O                   
managed              O                    O                   
with                 O                    O                   
IV                   O                    O                   
fluids               O                    O                   
and                  O                    O                   
subsequently         O                    O                   
transitioned         O                    O                   
to                   O                    O                   
oral                 O                    O                   
metoprolol           B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
is                   O                    O                   
stable               O                    O                   
for                  O                    O                   
discharge            O                    O                   
and                  O                    O                   
instructed           O                    O                   
to                   O                    O                   
follow               O                    O                   
up                   O                    O                   
with                 O                    O                   
primary              O                    O                   
care                 O                    O                   
for                  O                    O                   
monitoring           O                    O                   
of                   O                    O                   
alzheimer            B-DISEASE            B-DISEASE           
'                    I-DISEASE            I-DISEASE           
s                    I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 56:
[CLS]                O                    O                   
Discharge            O                    O                   
Summary              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
was                  O                    O                   
admitted             O                    O                   
for                  O                    O                   
an                   O                    O                   
acute                O                    O                   
exacerbation         O                    O                   
of                   O                    O                   
fibromyalgia         B-DISEASE            B-DISEASE           
.                    O                    O                   
During               O                    O                   
the                  O                    O                   
hospital             O                    O                   
stay                 O                    O                   
,                    O                    O                   
symptoms             O                    O                   
were                 O                    O                   
initially            O                    O                   
managed              O                    O                   
with                 O                    O                   
IV                   O                    O                   
fluids               O                    O                   
and                  O                    O                   
subsequently         O                    O                   
transitioned         O                    O                   
to                   O                    O                   
oral                 O                    O                   
pembrolizumab        B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
is                   O                    O                   
stable               O                    O                   
for                  O                    O                   
discharge            O                    O                   
and                  O                    O                   
instructed           O                    O                   
to                   O                    O                   
follow               O                    O                   
up                   O                    O                   
with                 O                    O                   
primary              O                    O                   
care                 O                    O                   
for                  O                    O                   
monitoring           O                    O                   
of                   O                    O                   
fibromyalgia         B-DISEASE            B-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 57:
[CLS]                O                    O                   
Emergent             O                    O                   
care                 O                    O                   
note                 O                    O                   
:                    O                    O                   
Patient              O                    O                   
found                O                    O                   
unresponsive         O                    O                   
.                    O                    O                   
Medical              O                    O                   
alert                O                    O                   
bracelet             O                    O                   
indicates            O                    O                   
lupus                B-DISEASE            O                   
.                    O                    O                   
EMS                  O                    O                   
administered         O                    O                   
naloxone             O                    O                   
without              O                    O                   
effect               O                    O                   
.                    O                    O                   
Family               O                    O                   
arrived              O                    O                   
and                  O                    O                   
confirmed            O                    O                   
patient              O                    O                   
takes                O                    O                   
gluten               B-MEDICATION         O                   
-                    I-MEDICATION         I-MEDICATION        
free                 I-MEDICATION         O                   
diet                 I-MEDICATION         O                   
for                  O                    O                   
the                  O                    O                   
condition            O                    O                   
.                    O                    O                   
Transported          O                    O                   
to                   O                    O                   
ICU                  O                    O                   
for                  O                    O                   
further              O                    O                   
management           O                    O                   
of                   O                    O                   
status               O                    O                   
epilepticus          O                    O                   
secondary            O                    O                   
to                   O                    O                   
lupus                B-DISEASE            O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 58:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
hepatitis            B-DISEASE            B-DISEASE           
c                    I-DISEASE            I-DISEASE           
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
isoniazid            B-MEDICATION         B-MEDICATION        
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
hepatitis            B-DISEASE            B-DISEASE           
c                    I-DISEASE            I-DISEASE           
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 59:
[CLS]                O                    O                   
Dermatology          O                    O                   
consult              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
presents             O                    O                   
with                 O                    O                   
a                    O                    O                   
diffuse              O                    O                   
rash                 O                    O                   
.                    O                    O                   
Differential         O                    O                   
diagnosis            O                    O                   
includes             O                    O                   
drug                 O                    O                   
eruption             O                    O                   
from                 O                    O                   
recent               O                    O                   
initiation           O                    O                   
of                   O                    O                   
omeprazole           B-MEDICATION         B-MEDICATION        
versus               O                    O                   
cutanous             O                    O                   
manifestation        O                    O                   
of                   O                    O                   
underlying           O                    O                   
tuberculosis         B-DISEASE            O                   
.                    O                    O                   
Biopsy               O                    O                   
performed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 60:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
sarcoidosis          B-DISEASE            B-DISEASE           
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
morphine             B-MEDICATION         B-MEDICATION        
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
sarcoidosis          B-DISEASE            B-DISEASE           
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 61:
[CLS]                O                    O                   
Assessment           O                    O                   
and                  O                    O                   
Plan                 O                    O                   
:                    O                    O                   
#                    O                    O                   
sarcoidosis          B-DISEASE            B-DISEASE           
-                    O                    O                   
largely              O                    O                   
controlled           O                    O                   
but                  O                    O                   
recent               O                    O                   
stress               O                    O                   
has                  O                    O                   
caused               O                    O                   
an                   O                    O                   
uptick               O                    O                   
in                   O                    O                   
symptoms             O                    O                   
.                    O                    O                   
We                   O                    O                   
will                 O                    O                   
increase             O                    O                   
the                  O                    O                   
dosage               O                    O                   
of                   O                    O                   
hydrochlorothiazide  B-MEDICATION         B-MEDICATION        
from                 O                    O                   
10mg                 O                    O                   
to                   O                    O                   
20mg                 O                    O                   
daily                O                    O                   
.                    O                    O                   
Patient              O                    O                   
was                  O                    O                   
advised              O                    O                   
to                   O                    O                   
monitor              O                    O                   
for                  O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
#                    O                    O                   
Hypertension         O                    O                   
-                    O                    O                   
stable               O                    O                   
.                    O                    O                   
#                    O                    O                   
Diabetes             O                    O                   
-                    O                    O                   
diet                 O                    O                   
controlled           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 62:
[CLS]                O                    O                   
The                  O                    O                   
62                   O                    O                   
-                    O                    O                   
year                 O                    O                   
-                    O                    O                   
old                  O                    O                   
female               O                    O                   
patient              O                    O                   
with                 O                    O                   
a                    O                    O                   
history              O                    O                   
of                   O                    O                   
fibromyalgia         B-DISEASE            B-DISEASE           
returns              O                    O                   
for                  O                    O                   
routine              O                    O                   
follow               O                    O                   
-                    O                    O                   
up                   O                    O                   
.                    O                    O                   
She                  O                    O                   
states               O                    O                   
that                 O                    O                   
the                  O                    O                   
metoprolol           B-MEDICATION         B-MEDICATION        
prescribed           O                    O                   
at                   O                    O                   
the                  O                    O                   
last                 O                    O                   
visit                O                    O                   
has                  O                    O                   
significantly        O                    O                   
reduced              O                    O                   
her                  O                    O                   
pain                 O                    O                   
levels               O                    O                   
.                    O                    O                   
However              O                    O                   
,                    O                    O                   
she                  O                    O                   
is                   O                    O                   
concerned            O                    O                   
about                O                    O                   
potential            O                    O                   
long                 O                    O                   
-                    O                    O                   
term                 O                    O                   
interactions         O                    O                   
between              O                    O                   
metoprolol           B-MEDICATION         B-MEDICATION        
and                  O                    O                   
her                  O                    O                   
other                O                    O                   
supplements          O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 63:
[CLS]                O                    O                   
Dermatology          O                    O                   
consult              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
presents             O                    O                   
with                 O                    O                   
a                    O                    O                   
diffuse              O                    O                   
rash                 O                    O                   
.                    O                    O                   
Differential         O                    O                   
diagnosis            O                    O                   
includes             O                    O                   
drug                 O                    O                   
eruption             O                    O                   
from                 O                    O                   
recent               O                    O                   
initiation           O                    O                   
of                   O                    O                   
gabapentin           B-MEDICATION         B-MEDICATION        
versus               O                    O                   
cutanous             O                    O                   
manifestation        O                    O                   
of                   O                    O                   
underlying           O                    O                   
sleep                B-DISEASE            B-DISEASE           
apnea                I-DISEASE            I-DISEASE           
.                    O                    O                   
Biopsy               O                    O                   
performed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 64:
[CLS]                O                    O                   
Dermatology          O                    O                   
consult              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
presents             O                    O                   
with                 O                    O                   
a                    O                    O                   
diffuse              O                    O                   
rash                 O                    O                   
.                    O                    O                   
Differential         O                    O                   
diagnosis            O                    O                   
includes             O                    O                   
drug                 O                    O                   
eruption             O                    O                   
from                 O                    O                   
recent               O                    O                   
initiation           O                    O                   
of                   O                    O                   
jardiance            B-MEDICATION         B-MEDICATION        
versus               O                    O                   
cutanous             O                    O                   
manifestation        O                    O                   
of                   O                    O                   
underlying           O                    O                   
meningitis           B-DISEASE            B-DISEASE           
.                    O                    O                   
Biopsy               O                    O                   
performed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 65:
[CLS]                O                    O                   
Assessment           O                    O                   
and                  O                    O                   
Plan                 O                    O                   
:                    O                    O                   
#                    O                    O                   
osteoporosis         B-DISEASE            B-DISEASE           
-                    O                    O                   
largely              O                    O                   
controlled           O                    O                   
but                  O                    O                   
recent               O                    O                   
stress               O                    O                   
has                  O                    O                   
caused               O                    O                   
an                   O                    O                   
uptick               O                    O                   
in                   O                    O                   
symptoms             O                    O                   
.                    O                    O                   
We                   O                    O                   
will                 O                    O                   
increase             O                    O                   
the                  O                    O                   
dosage               O                    O                   
of                   O                    O                   
hydrochlorothiazide  B-MEDICATION         B-MEDICATION        
from                 O                    O                   
10mg                 O                    O                   
to                   O                    O                   
20mg                 O                    O                   
daily                O                    O                   
.                    O                    O                   
Patient              O                    O                   
was                  O                    O                   
advised              O                    O                   
to                   O                    O                   
monitor              O                    O                   
for                  O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
#                    O                    O                   
Hypertension         O                    O                   
-                    O                    O                   
stable               O                    O                   
.                    O                    O                   
#                    O                    O                   
Diabetes             O                    O                   
-                    O                    O                   
diet                 O                    O                   
controlled           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 66:
[CLS]                O                    O                   
Dermatology          O                    O                   
consult              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
presents             O                    O                   
with                 O                    O                   
a                    O                    O                   
diffuse              O                    O                   
rash                 O                    O                   
.                    O                    O                   
Differential         O                    O                   
diagnosis            O                    O                   
includes             O                    O                   
drug                 O                    O                   
eruption             O                    O                   
from                 O                    O                   
recent               O                    O                   
initiation           O                    O                   
of                   O                    O                   
isoniazid            B-MEDICATION         B-MEDICATION        
versus               O                    O                   
cutanous             O                    O                   
manifestation        O                    O                   
of                   O                    O                   
underlying           O                    O                   
colon                B-DISEASE            B-DISEASE           
cancer               I-DISEASE            I-DISEASE           
.                    O                    O                   
Biopsy               O                    O                   
performed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 67:
[CLS]                O                    O                   
Discharge            O                    O                   
Summary              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
was                  O                    O                   
admitted             O                    O                   
for                  O                    O                   
an                   O                    O                   
acute                O                    O                   
exacerbation         O                    O                   
of                   O                    O                   
sarcoidosis          B-DISEASE            B-DISEASE           
.                    O                    O                   
During               O                    O                   
the                  O                    O                   
hospital             O                    O                   
stay                 O                    O                   
,                    O                    O                   
symptoms             O                    O                   
were                 O                    O                   
initially            O                    O                   
managed              O                    O                   
with                 O                    O                   
IV                   O                    O                   
fluids               O                    O                   
and                  O                    O                   
subsequently         O                    O                   
transitioned         O                    O                   
to                   O                    O                   
oral                 O                    O                   
ibuprofen            B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
is                   O                    O                   
stable               O                    O                   
for                  O                    O                   
discharge            O                    O                   
and                  O                    O                   
instructed           O                    O                   
to                   O                    O                   
follow               O                    O                   
up                   O                    O                   
with                 O                    O                   
primary              O                    O                   
care                 O                    O                   
for                  O                    O                   
monitoring           O                    O                   
of                   O                    O                   
sarcoidosis          B-DISEASE            B-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 68:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
parkinson            B-DISEASE            B-DISEASE           
'                    I-DISEASE            I-DISEASE           
s                    I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
sumatriptan          B-MEDICATION         O                   
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
parkinson            B-DISEASE            B-MEDICATION        
'                    I-DISEASE            I-DISEASE           
s                    I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 69:
[CLS]                O                    O                   
Discharge            O                    O                   
Summary              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
was                  O                    O                   
admitted             O                    O                   
for                  O                    O                   
an                   O                    O                   
acute                O                    O                   
exacerbation         O                    O                   
of                   O                    O                   
irritable            B-DISEASE            I-DISEASE           
bowel                I-DISEASE            B-DISEASE           
syndrome             I-DISEASE            O                   
.                    O                    O                   
During               O                    O                   
the                  O                    O                   
hospital             O                    O                   
stay                 O                    O                   
,                    O                    O                   
symptoms             O                    O                   
were                 O                    O                   
initially            O                    O                   
managed              O                    O                   
with                 O                    O                   
IV                   O                    O                   
fluids               O                    O                   
and                  O                    O                   
subsequently         O                    O                   
transitioned         O                    O                   
to                   O                    O                   
oral                 O                    O                   
hydrochlorothiazide  B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
is                   O                    O                   
stable               O                    O                   
for                  O                    O                   
discharge            O                    O                   
and                  O                    O                   
instructed           O                    O                   
to                   O                    O                   
follow               O                    O                   
up                   O                    O                   
with                 O                    O                   
primary              O                    O                   
care                 O                    O                   
for                  O                    O                   
monitoring           O                    O                   
of                   O                    O                   
irritable            B-DISEASE            O                   
bowel                I-DISEASE            O                   
syndrome             I-DISEASE            O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 70:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
meningitis           B-DISEASE            B-DISEASE           
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
gluten               B-MEDICATION         O                   
-                    I-MEDICATION         I-MEDICATION        
free                 I-MEDICATION         O                   
diet                 I-MEDICATION         O                   
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
meningitis           B-DISEASE            B-DISEASE           
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 71:
[CLS]                O                    O                   
Subjective           O                    O                   
:                    O                    O                   
Patient              O                    O                   
reports              O                    O                   
feeling              O                    O                   
'                    O                    O                   
unwell               O                    O                   
'                    O                    O                   
for                  O                    O                   
3                    O                    O                   
days                 O                    O                   
.                    O                    O                   
History              O                    O                   
of                   O                    O                   
present              O                    O                   
illness              O                    O                   
is                   O                    O                   
consistent           O                    O                   
with                 O                    O                   
a                    O                    O                   
flare                O                    O                   
of                   O                    O                   
atrial               B-DISEASE            B-DISEASE           
fibrillation         I-DISEASE            I-DISEASE           
.                    O                    O                   
She                  O                    O                   
mentions             O                    O                   
she                  O                    O                   
ran                  O                    O                   
out                  O                    O                   
of                   O                    O                   
carbamazepine        B-MEDICATION         B-MEDICATION        
4                    O                    O                   
days                 O                    O                   
ago                  O                    O                   
.                    O                    O                   
Objective            O                    O                   
:                    O                    O                   
Vitals               O                    O                   
stable               O                    O                   
.                    O                    O                   
Plan                 O                    O                   
:                    O                    O                   
Restart              O                    O                   
carbamazepine        B-MEDICATION         B-MEDICATION        
immediately          O                    O                   
and                  O                    O                   
schedule             O                    O                   
lab                  O                    O                   
work                 O                    O                   
to                   O                    O                   
assess               O                    O                   
specificity          O                    O                   
of                   O                    O                   
atrial               B-DISEASE            B-DISEASE           
fibrillation         I-DISEASE            I-DISEASE           
markers              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 72:
[CLS]                O                    O                   
Dermatology          O                    O                   
consult              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
presents             O                    O                   
with                 O                    O                   
a                    O                    O                   
diffuse              O                    O                   
rash                 O                    O                   
.                    O                    O                   
Differential         O                    O                   
diagnosis            O                    O                   
includes             O                    O                   
drug                 O                    O                   
eruption             O                    O                   
from                 O                    O                   
recent               O                    O                   
initiation           O                    O                   
of                   O                    O                   
jardiance            B-MEDICATION         B-MEDICATION        
versus               O                    O                   
cutanous             O                    O                   
manifestation        O                    O                   
of                   O                    O                   
underlying           O                    O                   
irritable            B-DISEASE            B-MEDICATION        
bowel                I-DISEASE            B-MEDICATION        
syndrome             I-DISEASE            O                   
.                    O                    O                   
Biopsy               O                    O                   
performed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 73:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
ibuprofen            B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
diverticulitis       B-DISEASE            B-DISEASE           
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
ibuprofen            B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 74:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
melanoma             B-DISEASE            B-DISEASE           
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
bupropion            B-MEDICATION         B-MEDICATION        
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
melanoma             B-DISEASE            B-DISEASE           
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 75:
[CLS]                O                    O                   
Subjective           O                    O                   
:                    O                    O                   
Patient              O                    O                   
reports              O                    O                   
feeling              O                    O                   
'                    O                    O                   
unwell               O                    O                   
'                    O                    O                   
for                  O                    O                   
3                    O                    O                   
days                 O                    O                   
.                    O                    O                   
History              O                    O                   
of                   O                    O                   
present              O                    O                   
illness              O                    O                   
is                   O                    O                   
consistent           O                    O                   
with                 O                    O                   
a                    O                    O                   
flare                O                    O                   
of                   O                    O                   
celiac               B-DISEASE            B-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
She                  O                    O                   
mentions             O                    O                   
she                  O                    O                   
ran                  O                    O                   
out                  O                    O                   
of                   O                    O                   
xarelto              B-MEDICATION         B-MEDICATION        
4                    O                    O                   
days                 O                    O                   
ago                  O                    O                   
.                    O                    O                   
Objective            O                    O                   
:                    O                    O                   
Vitals               O                    O                   
stable               O                    O                   
.                    O                    O                   
Plan                 O                    O                   
:                    O                    O                   
Restart              O                    O                   
xarelto              B-MEDICATION         O                   
immediately          O                    O                   
and                  O                    O                   
schedule             O                    O                   
lab                  O                    O                   
work                 O                    O                   
to                   O                    O                   
assess               O                    O                   
specificity          O                    O                   
of                   O                    O                   
celiac               B-DISEASE            B-DISEASE           
disease              I-DISEASE            I-DISEASE           
markers              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 76:
[CLS]                O                    O                   
Dermatology          O                    O                   
consult              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
presents             O                    O                   
with                 O                    O                   
a                    O                    O                   
diffuse              O                    O                   
rash                 O                    O                   
.                    O                    O                   
Differential         O                    O                   
diagnosis            O                    O                   
includes             O                    O                   
drug                 O                    O                   
eruption             O                    O                   
from                 O                    O                   
recent               O                    O                   
initiation           O                    O                   
of                   O                    O                   
sumatriptan          B-MEDICATION         O                   
versus               O                    O                   
cutanous             O                    O                   
manifestation        O                    O                   
of                   O                    O                   
underlying           O                    O                   
hepatitis            B-DISEASE            B-DISEASE           
b                    I-DISEASE            O                   
.                    O                    O                   
Biopsy               O                    O                   
performed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 77:
[CLS]                O                    O                   
Subjective           O                    O                   
:                    O                    O                   
Patient              O                    O                   
reports              O                    O                   
feeling              O                    O                   
'                    O                    O                   
unwell               O                    O                   
'                    O                    O                   
for                  O                    O                   
3                    O                    O                   
days                 O                    O                   
.                    O                    O                   
History              O                    O                   
of                   O                    O                   
present              O                    O                   
illness              O                    O                   
is                   O                    O                   
consistent           O                    O                   
with                 O                    O                   
a                    O                    O                   
flare                O                    O                   
of                   O                    O                   
multiple             B-DISEASE            B-DISEASE           
sclerosis            I-DISEASE            I-DISEASE           
.                    O                    O                   
She                  O                    O                   
mentions             O                    O                   
she                  O                    O                   
ran                  O                    O                   
out                  O                    O                   
of                   O                    O                   
sertraline           B-MEDICATION         B-MEDICATION        
4                    O                    O                   
days                 O                    O                   
ago                  O                    O                   
.                    O                    O                   
Objective            O                    O                   
:                    O                    O                   
Vitals               O                    O                   
stable               O                    O                   
.                    O                    O                   
Plan                 O                    O                   
:                    O                    O                   
Restart              O                    O                   
sertraline           B-MEDICATION         B-MEDICATION        
immediately          O                    O                   
and                  O                    O                   
schedule             O                    O                   
lab                  O                    O                   
work                 O                    O                   
to                   O                    O                   
assess               O                    O                   
specificity          O                    O                   
of                   O                    O                   
multiple             B-DISEASE            B-DISEASE           
sclerosis            I-DISEASE            I-DISEASE           
markers              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 78:
[CLS]                O                    O                   
Discharge            O                    O                   
Summary              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
was                  O                    O                   
admitted             O                    O                   
for                  O                    O                   
an                   O                    O                   
acute                O                    O                   
exacerbation         O                    O                   
of                   O                    O                   
migraine             B-DISEASE            B-DISEASE           
.                    O                    O                   
During               O                    O                   
the                  O                    O                   
hospital             O                    O                   
stay                 O                    O                   
,                    O                    O                   
symptoms             O                    O                   
were                 O                    O                   
initially            O                    O                   
managed              O                    O                   
with                 O                    O                   
IV                   O                    O                   
fluids               O                    O                   
and                  O                    O                   
subsequently         O                    O                   
transitioned         O                    O                   
to                   O                    O                   
oral                 O                    O                   
jardiance            B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
is                   O                    O                   
stable               O                    O                   
for                  O                    O                   
discharge            O                    O                   
and                  O                    O                   
instructed           O                    O                   
to                   O                    O                   
follow               O                    O                   
up                   O                    O                   
with                 O                    O                   
primary              O                    O                   
care                 O                    O                   
for                  O                    O                   
monitoring           O                    O                   
of                   O                    O                   
migraine             B-DISEASE            B-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 79:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
fluoxetine           B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
stroke               B-DISEASE            B-DISEASE           
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
fluoxetine           B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 80:
[CLS]                O                    O                   
Dermatology          O                    O                   
consult              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
presents             O                    O                   
with                 O                    O                   
a                    O                    O                   
diffuse              O                    O                   
rash                 O                    O                   
.                    O                    O                   
Differential         O                    O                   
diagnosis            O                    O                   
includes             O                    O                   
drug                 O                    O                   
eruption             O                    O                   
from                 O                    O                   
recent               O                    O                   
initiation           O                    O                   
of                   O                    O                   
sertraline           B-MEDICATION         B-MEDICATION        
versus               O                    O                   
cutanous             O                    O                   
manifestation        O                    O                   
of                   O                    O                   
underlying           O                    O                   
vertigo              B-DISEASE            B-DISEASE           
.                    O                    O                   
Biopsy               O                    O                   
performed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 81:
[CLS]                O                    O                   
Assessment           O                    O                   
and                  O                    O                   
Plan                 O                    O                   
:                    O                    O                   
#                    O                    O                   
anemia               B-DISEASE            B-DISEASE           
-                    O                    O                   
largely              O                    O                   
controlled           O                    O                   
but                  O                    O                   
recent               O                    O                   
stress               O                    O                   
has                  O                    O                   
caused               O                    O                   
an                   O                    O                   
uptick               O                    O                   
in                   O                    O                   
symptoms             O                    O                   
.                    O                    O                   
We                   O                    O                   
will                 O                    O                   
increase             O                    O                   
the                  O                    O                   
dosage               O                    O                   
of                   O                    O                   
eliquis              B-MEDICATION         B-MEDICATION        
from                 O                    O                   
10mg                 O                    O                   
to                   O                    O                   
20mg                 O                    O                   
daily                O                    O                   
.                    O                    O                   
Patient              O                    O                   
was                  O                    O                   
advised              O                    O                   
to                   O                    O                   
monitor              O                    O                   
for                  O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
#                    O                    O                   
Hypertension         O                    O                   
-                    O                    O                   
stable               O                    O                   
.                    O                    O                   
#                    O                    O                   
Diabetes             O                    O                   
-                    O                    O                   
diet                 O                    O                   
controlled           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 82:
[CLS]                O                    O                   
Emergent             O                    O                   
care                 O                    O                   
note                 O                    O                   
:                    O                    O                   
Patient              O                    O                   
found                O                    O                   
unresponsive         O                    O                   
.                    O                    O                   
Medical              O                    O                   
alert                O                    O                   
bracelet             O                    O                   
indicates            O                    O                   
fibromyalgia         B-DISEASE            B-DISEASE           
.                    O                    O                   
EMS                  O                    O                   
administered         O                    O                   
naloxone             O                    O                   
without              O                    O                   
effect               O                    O                   
.                    O                    O                   
Family               O                    O                   
arrived              O                    O                   
and                  O                    O                   
confirmed            O                    O                   
patient              O                    O                   
takes                O                    O                   
hydrochlorothiazide  B-MEDICATION         B-MEDICATION        
for                  O                    O                   
the                  O                    O                   
condition            O                    O                   
.                    O                    O                   
Transported          O                    O                   
to                   O                    O                   
ICU                  O                    O                   
for                  O                    O                   
further              O                    O                   
management           O                    O                   
of                   O                    O                   
status               O                    O                   
epilepticus          O                    O                   
secondary            O                    O                   
to                   O                    O                   
fibromyalgia         B-DISEASE            B-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 83:
[CLS]                O                    O                   
Dermatology          O                    O                   
consult              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
presents             O                    O                   
with                 O                    O                   
a                    O                    O                   
diffuse              O                    O                   
rash                 O                    O                   
.                    O                    O                   
Differential         O                    O                   
diagnosis            O                    O                   
includes             O                    O                   
drug                 O                    O                   
eruption             O                    O                   
from                 O                    O                   
recent               O                    O                   
initiation           O                    O                   
of                   O                    O                   
pembrolizumab        B-MEDICATION         B-MEDICATION        
versus               O                    O                   
cutanous             O                    O                   
manifestation        O                    O                   
of                   O                    O                   
underlying           O                    O                   
epilepsy             B-DISEASE            B-DISEASE           
.                    O                    O                   
Biopsy               O                    O                   
performed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 84:
[CLS]                O                    O                   
The                  O                    O                   
62                   O                    O                   
-                    O                    O                   
year                 O                    O                   
-                    O                    O                   
old                  O                    O                   
female               O                    O                   
patient              O                    O                   
with                 O                    O                   
a                    O                    O                   
history              O                    O                   
of                   O                    O                   
hepatitis            B-DISEASE            B-DISEASE           
c                    I-DISEASE            I-DISEASE           
returns              O                    O                   
for                  O                    O                   
routine              O                    O                   
follow               O                    O                   
-                    O                    O                   
up                   O                    O                   
.                    O                    O                   
She                  O                    O                   
states               O                    O                   
that                 O                    O                   
the                  O                    O                   
pembrolizumab        B-MEDICATION         B-MEDICATION        
prescribed           O                    O                   
at                   O                    O                   
the                  O                    O                   
last                 O                    O                   
visit                O                    O                   
has                  O                    O                   
significantly        O                    O                   
reduced              O                    O                   
her                  O                    O                   
pain                 O                    O                   
levels               O                    O                   
.                    O                    O                   
However              O                    O                   
,                    O                    O                   
she                  O                    O                   
is                   O                    O                   
concerned            O                    O                   
about                O                    O                   
potential            O                    O                   
long                 O                    O                   
-                    O                    O                   
term                 O                    O                   
interactions         O                    O                   
between              O                    O                   
pembrolizumab        B-MEDICATION         B-MEDICATION        
and                  O                    O                   
her                  O                    O                   
other                O                    O                   
supplements          O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 85:
[CLS]                O                    O                   
Emergent             O                    O                   
care                 O                    O                   
note                 O                    O                   
:                    O                    O                   
Patient              O                    O                   
found                O                    O                   
unresponsive         O                    O                   
.                    O                    O                   
Medical              O                    O                   
alert                O                    O                   
bracelet             O                    O                   
indicates            O                    O                   
meningitis           B-DISEASE            B-DISEASE           
.                    O                    O                   
EMS                  O                    O                   
administered         O                    O                   
naloxone             O                    O                   
without              O                    O                   
effect               O                    O                   
.                    O                    O                   
Family               O                    O                   
arrived              O                    O                   
and                  O                    O                   
confirmed            O                    O                   
patient              O                    O                   
takes                O                    O                   
ibuprofen            B-MEDICATION         B-MEDICATION        
for                  O                    O                   
the                  O                    O                   
condition            O                    O                   
.                    O                    O                   
Transported          O                    O                   
to                   O                    O                   
ICU                  O                    O                   
for                  O                    O                   
further              O                    O                   
management           O                    O                   
of                   O                    O                   
status               O                    O                   
epilepticus          O                    O                   
secondary            O                    O                   
to                   O                    O                   
meningitis           B-DISEASE            B-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 86:
[CLS]                O                    O                   
The                  O                    O                   
62                   O                    O                   
-                    O                    O                   
year                 O                    O                   
-                    O                    O                   
old                  O                    O                   
female               O                    O                   
patient              O                    O                   
with                 O                    O                   
a                    O                    O                   
history              O                    O                   
of                   O                    O                   
coronary             B-DISEASE            O                   
artery               I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
returns              O                    O                   
for                  O                    O                   
routine              O                    O                   
follow               O                    O                   
-                    O                    O                   
up                   O                    O                   
.                    O                    O                   
She                  O                    O                   
states               O                    O                   
that                 O                    O                   
the                  O                    O                   
hydrochlorothiazide  B-MEDICATION         B-MEDICATION        
prescribed           O                    O                   
at                   O                    O                   
the                  O                    O                   
last                 O                    O                   
visit                O                    O                   
has                  O                    O                   
significantly        O                    O                   
reduced              O                    O                   
her                  O                    O                   
pain                 O                    O                   
levels               O                    O                   
.                    O                    O                   
However              O                    O                   
,                    O                    O                   
she                  O                    O                   
is                   O                    O                   
concerned            O                    O                   
about                O                    O                   
potential            O                    O                   
long                 O                    O                   
-                    O                    O                   
term                 O                    O                   
interactions         O                    O                   
between              O                    O                   
hydrochlorothiazide  B-MEDICATION         B-MEDICATION        
and                  O                    O                   
her                  O                    O                   
other                O                    O                   
supplements          O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 87:
[CLS]                O                    O                   
Emergent             O                    O                   
care                 O                    O                   
note                 O                    O                   
:                    O                    O                   
Patient              O                    O                   
found                O                    O                   
unresponsive         O                    O                   
.                    O                    O                   
Medical              O                    O                   
alert                O                    O                   
bracelet             O                    O                   
indicates            O                    O                   
sleep                B-DISEASE            B-DISEASE           
apnea                I-DISEASE            I-DISEASE           
.                    O                    O                   
EMS                  O                    O                   
administered         O                    O                   
naloxone             O                    O                   
without              O                    O                   
effect               O                    O                   
.                    O                    O                   
Family               O                    O                   
arrived              O                    O                   
and                  O                    O                   
confirmed            O                    O                   
patient              O                    O                   
takes                O                    O                   
pembrolizumab        B-MEDICATION         B-MEDICATION        
for                  O                    O                   
the                  O                    O                   
condition            O                    O                   
.                    O                    O                   
Transported          O                    O                   
to                   O                    O                   
ICU                  O                    O                   
for                  O                    O                   
further              O                    O                   
management           O                    O                   
of                   O                    O                   
status               O                    O                   
epilepticus          O                    O                   
secondary            O                    O                   
to                   O                    O                   
sleep                B-DISEASE            B-DISEASE           
apnea                I-DISEASE            I-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 88:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
ciprofloxacin        B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
multiple             B-DISEASE            B-DISEASE           
sclerosis            I-DISEASE            I-DISEASE           
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
ciprofloxacin        B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 89:
[CLS]                O                    O                   
Discharge            O                    O                   
Summary              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
was                  O                    O                   
admitted             O                    O                   
for                  O                    O                   
an                   O                    O                   
acute                O                    O                   
exacerbation         O                    O                   
of                   O                    O                   
alzheimer            B-DISEASE            B-DISEASE           
'                    I-DISEASE            I-DISEASE           
s                    I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
During               O                    O                   
the                  O                    O                   
hospital             O                    O                   
stay                 O                    O                   
,                    O                    O                   
symptoms             O                    O                   
were                 O                    O                   
initially            O                    O                   
managed              O                    O                   
with                 O                    O                   
IV                   O                    O                   
fluids               O                    O                   
and                  O                    O                   
subsequently         O                    O                   
transitioned         O                    O                   
to                   O                    O                   
oral                 O                    O                   
hydroxychloroquine   B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
is                   O                    O                   
stable               O                    O                   
for                  O                    O                   
discharge            O                    O                   
and                  O                    O                   
instructed           O                    O                   
to                   O                    O                   
follow               O                    O                   
up                   O                    O                   
with                 O                    O                   
primary              O                    O                   
care                 O                    O                   
for                  O                    O                   
monitoring           O                    O                   
of                   O                    O                   
alzheimer            B-DISEASE            B-DISEASE           
'                    I-DISEASE            I-DISEASE           
s                    I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 90:
[CLS]                O                    O                   
Discharge            O                    O                   
Summary              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
was                  O                    O                   
admitted             O                    O                   
for                  O                    O                   
an                   O                    O                   
acute                O                    O                   
exacerbation         O                    O                   
of                   O                    O                   
atrial               B-DISEASE            B-DISEASE           
fibrillation         I-DISEASE            I-DISEASE           
.                    O                    O                   
During               O                    O                   
the                  O                    O                   
hospital             O                    O                   
stay                 O                    O                   
,                    O                    O                   
symptoms             O                    O                   
were                 O                    O                   
initially            O                    O                   
managed              O                    O                   
with                 O                    O                   
IV                   O                    O                   
fluids               O                    O                   
and                  O                    O                   
subsequently         O                    O                   
transitioned         O                    O                   
to                   O                    O                   
oral                 O                    O                   
sertraline           B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
is                   O                    O                   
stable               O                    O                   
for                  O                    O                   
discharge            O                    O                   
and                  O                    O                   
instructed           O                    O                   
to                   O                    O                   
follow               O                    O                   
up                   O                    O                   
with                 O                    O                   
primary              O                    O                   
care                 O                    O                   
for                  O                    O                   
monitoring           O                    O                   
of                   O                    O                   
atrial               B-DISEASE            B-DISEASE           
fibrillation         I-DISEASE            I-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 91:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
melanoma             B-DISEASE            B-DISEASE           
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
pembrolizumab        B-MEDICATION         B-MEDICATION        
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
melanoma             B-DISEASE            B-DISEASE           
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 92:
[CLS]                O                    O                   
Subjective           O                    O                   
:                    O                    O                   
Patient              O                    O                   
reports              O                    O                   
feeling              O                    O                   
'                    O                    O                   
unwell               O                    O                   
'                    O                    O                   
for                  O                    O                   
3                    O                    O                   
days                 O                    O                   
.                    O                    O                   
History              O                    O                   
of                   O                    O                   
present              O                    O                   
illness              O                    O                   
is                   O                    O                   
consistent           O                    O                   
with                 O                    O                   
a                    O                    O                   
flare                O                    O                   
of                   O                    O                   
atrial               B-DISEASE            B-DISEASE           
fibrillation         I-DISEASE            I-DISEASE           
.                    O                    O                   
She                  O                    O                   
mentions             O                    O                   
she                  O                    O                   
ran                  O                    O                   
out                  O                    O                   
of                   O                    O                   
jardiance            B-MEDICATION         B-MEDICATION        
4                    O                    O                   
days                 O                    O                   
ago                  O                    O                   
.                    O                    O                   
Objective            O                    O                   
:                    O                    O                   
Vitals               O                    O                   
stable               O                    O                   
.                    O                    O                   
Plan                 O                    O                   
:                    O                    O                   
Restart              O                    O                   
jardiance            B-MEDICATION         B-MEDICATION        
immediately          O                    O                   
and                  O                    O                   
schedule             O                    O                   
lab                  O                    O                   
work                 O                    O                   
to                   O                    O                   
assess               O                    O                   
specificity          O                    O                   
of                   O                    O                   
atrial               B-DISEASE            B-DISEASE           
fibrillation         I-DISEASE            I-DISEASE           
markers              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 93:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
insulin              B-MEDICATION         B-MEDICATION        
glargine             I-MEDICATION         O                   
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
stroke               B-DISEASE            B-DISEASE           
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
insulin              B-MEDICATION         B-MEDICATION        
glargine             I-MEDICATION         O                   
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 94:
[CLS]                O                    O                   
Dermatology          O                    O                   
consult              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
presents             O                    O                   
with                 O                    O                   
a                    O                    O                   
diffuse              O                    O                   
rash                 O                    O                   
.                    O                    O                   
Differential         O                    O                   
diagnosis            O                    O                   
includes             O                    O                   
drug                 O                    O                   
eruption             O                    O                   
from                 O                    O                   
recent               O                    O                   
initiation           O                    O                   
of                   O                    O                   
isoniazid            B-MEDICATION         B-MEDICATION        
versus               O                    O                   
cutanous             O                    O                   
manifestation        O                    O                   
of                   O                    O                   
underlying           O                    O                   
coronary             B-DISEASE            O                   
artery               I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
Biopsy               O                    O                   
performed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 95:
[CLS]                O                    O                   
The                  O                    O                   
62                   O                    O                   
-                    O                    O                   
year                 O                    O                   
-                    O                    O                   
old                  O                    O                   
female               O                    O                   
patient              O                    O                   
with                 O                    O                   
a                    O                    O                   
history              O                    O                   
of                   O                    O                   
stroke               B-DISEASE            B-DISEASE           
returns              O                    O                   
for                  O                    O                   
routine              O                    O                   
follow               O                    O                   
-                    O                    O                   
up                   O                    O                   
.                    O                    O                   
She                  O                    O                   
states               O                    O                   
that                 O                    O                   
the                  O                    O                   
metoprolol           B-MEDICATION         B-MEDICATION        
prescribed           O                    O                   
at                   O                    O                   
the                  O                    O                   
last                 O                    O                   
visit                O                    O                   
has                  O                    O                   
significantly        O                    O                   
reduced              O                    O                   
her                  O                    O                   
pain                 O                    O                   
levels               O                    O                   
.                    O                    O                   
However              O                    O                   
,                    O                    O                   
she                  O                    O                   
is                   O                    O                   
concerned            O                    O                   
about                O                    O                   
potential            O                    O                   
long                 O                    O                   
-                    O                    O                   
term                 O                    O                   
interactions         O                    O                   
between              O                    O                   
metoprolol           B-MEDICATION         B-MEDICATION        
and                  O                    O                   
her                  O                    O                   
other                O                    O                   
supplements          O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 96:
[CLS]                O                    O                   
Radiology            O                    O                   
Report               O                    O                   
:                    O                    O                   
Chest                O                    O                   
X                    O                    O                   
-                    O                    O                   
ray                  O                    O                   
shows                O                    O                   
patchy               O                    O                   
infiltrates          O                    O                   
consistent           O                    O                   
with                 O                    O                   
celiac               B-DISEASE            B-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
Clinical             O                    O                   
correlation          O                    O                   
is                   O                    O                   
recommended          O                    O                   
.                    O                    O                   
Given                O                    O                   
the                  O                    O                   
imaging              O                    O                   
findings             O                    O                   
and                  O                    O                   
clinical             O                    O                   
presentation         O                    O                   
,                    O                    O                   
empiric              O                    O                   
treatment            O                    O                   
with                 O                    O                   
insulin              B-MEDICATION         B-MEDICATION        
glargine             I-MEDICATION         O                   
should               O                    O                   
be                   O                    O                   
considered           O                    O                   
pending              O                    O                   
culture              O                    O                   
results              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 97:
[CLS]                O                    O                   
Radiology            O                    O                   
Report               O                    O                   
:                    O                    O                   
Chest                O                    O                   
X                    O                    O                   
-                    O                    O                   
ray                  O                    O                   
shows                O                    O                   
patchy               O                    O                   
infiltrates          O                    O                   
consistent           O                    O                   
with                 O                    O                   
irritable            B-DISEASE            O                   
bowel                I-DISEASE            O                   
syndrome             I-DISEASE            O                   
.                    O                    O                   
Clinical             O                    O                   
correlation          O                    O                   
is                   O                    O                   
recommended          O                    O                   
.                    O                    O                   
Given                O                    O                   
the                  O                    O                   
imaging              O                    O                   
findings             O                    O                   
and                  O                    O                   
clinical             O                    O                   
presentation         O                    O                   
,                    O                    O                   
empiric              O                    O                   
treatment            O                    O                   
with                 O                    O                   
insulin              B-MEDICATION         B-MEDICATION        
glargine             I-MEDICATION         O                   
should               O                    O                   
be                   O                    O                   
considered           O                    O                   
pending              O                    O                   
culture              O                    O                   
results              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 98:
[CLS]                O                    O                   
Subjective           O                    O                   
:                    O                    O                   
Patient              O                    O                   
reports              O                    O                   
feeling              O                    O                   
'                    O                    O                   
unwell               O                    O                   
'                    O                    O                   
for                  O                    O                   
3                    O                    O                   
days                 O                    O                   
.                    O                    O                   
History              O                    O                   
of                   O                    O                   
present              O                    O                   
illness              O                    O                   
is                   O                    O                   
consistent           O                    O                   
with                 O                    O                   
a                    O                    O                   
flare                O                    O                   
of                   O                    O                   
alzheimer            B-DISEASE            B-DISEASE           
'                    I-DISEASE            I-DISEASE           
s                    I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
She                  O                    O                   
mentions             O                    O                   
she                  O                    O                   
ran                  O                    O                   
out                  O                    O                   
of                   O                    O                   
morphine             B-MEDICATION         B-MEDICATION        
4                    O                    O                   
days                 O                    O                   
ago                  O                    O                   
.                    O                    O                   
Objective            O                    O                   
:                    O                    O                   
Vitals               O                    O                   
stable               O                    O                   
.                    O                    O                   
Plan                 O                    O                   
:                    O                    O                   
Restart              O                    O                   
morphine             B-MEDICATION         B-MEDICATION        
immediately          O                    O                   
and                  O                    O                   
schedule             O                    O                   
lab                  O                    O                   
work                 O                    O                   
to                   O                    O                   
assess               O                    O                   
specificity          O                    O                   
of                   O                    O                   
alzheimer            B-DISEASE            B-DISEASE           
'                    I-DISEASE            I-DISEASE           
s                    I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
markers              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 99:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
sumatriptan          B-MEDICATION         O                   
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
lupus                B-DISEASE            B-DISEASE           
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
sumatriptan          B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 100:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
methotrexate         B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
epilepsy             B-DISEASE            B-DISEASE           
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
methotrexate         B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 101:
[CLS]                O                    O                   
Emergent             O                    O                   
care                 O                    O                   
note                 O                    O                   
:                    O                    O                   
Patient              O                    O                   
found                O                    O                   
unresponsive         O                    O                   
.                    O                    O                   
Medical              O                    O                   
alert                O                    O                   
bracelet             O                    O                   
indicates            O                    O                   
multiple             B-DISEASE            B-DISEASE           
sclerosis            I-DISEASE            I-DISEASE           
.                    O                    O                   
EMS                  O                    O                   
administered         O                    O                   
naloxone             O                    O                   
without              O                    O                   
effect               O                    O                   
.                    O                    O                   
Family               O                    O                   
arrived              O                    O                   
and                  O                    O                   
confirmed            O                    O                   
patient              O                    O                   
takes                O                    O                   
jardiance            B-MEDICATION         B-MEDICATION        
for                  O                    O                   
the                  O                    O                   
condition            O                    O                   
.                    O                    O                   
Transported          O                    O                   
to                   O                    O                   
ICU                  O                    O                   
for                  O                    O                   
further              O                    O                   
management           O                    O                   
of                   O                    O                   
status               O                    O                   
epilepticus          O                    O                   
secondary            O                    O                   
to                   O                    O                   
multiple             B-DISEASE            B-DISEASE           
sclerosis            I-DISEASE            I-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 102:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
meningitis           B-DISEASE            B-DISEASE           
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
sertraline           B-MEDICATION         B-MEDICATION        
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
meningitis           B-DISEASE            B-DISEASE           
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 103:
[CLS]                O                    O                   
Subjective           O                    O                   
:                    O                    O                   
Patient              O                    O                   
reports              O                    O                   
feeling              O                    O                   
'                    O                    O                   
unwell               O                    O                   
'                    O                    O                   
for                  O                    O                   
3                    O                    O                   
days                 O                    O                   
.                    O                    O                   
History              O                    O                   
of                   O                    O                   
present              O                    O                   
illness              O                    O                   
is                   O                    O                   
consistent           O                    O                   
with                 O                    O                   
a                    O                    O                   
flare                O                    O                   
of                   O                    O                   
sleep                B-DISEASE            B-DISEASE           
apnea                I-DISEASE            I-DISEASE           
.                    O                    O                   
She                  O                    O                   
mentions             O                    O                   
she                  O                    O                   
ran                  O                    O                   
out                  O                    O                   
of                   O                    O                   
omeprazole           B-MEDICATION         B-MEDICATION        
4                    O                    O                   
days                 O                    O                   
ago                  O                    O                   
.                    O                    O                   
Objective            O                    O                   
:                    O                    O                   
Vitals               O                    O                   
stable               O                    O                   
.                    O                    O                   
Plan                 O                    O                   
:                    O                    O                   
Restart              O                    O                   
omeprazole           B-MEDICATION         B-MEDICATION        
immediately          O                    O                   
and                  O                    O                   
schedule             O                    O                   
lab                  O                    O                   
work                 O                    O                   
to                   O                    O                   
assess               O                    O                   
specificity          O                    O                   
of                   O                    O                   
sleep                B-DISEASE            B-DISEASE           
apnea                I-DISEASE            I-DISEASE           
markers              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 104:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
stroke               B-DISEASE            B-DISEASE           
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
insulin              B-MEDICATION         B-MEDICATION        
glargine             I-MEDICATION         O                   
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
stroke               B-DISEASE            B-DISEASE           
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 105:
[CLS]                O                    O                   
Radiology            O                    O                   
Report               O                    O                   
:                    O                    O                   
Chest                O                    O                   
X                    O                    O                   
-                    O                    O                   
ray                  O                    O                   
shows                O                    O                   
patchy               O                    O                   
infiltrates          O                    O                   
consistent           O                    O                   
with                 O                    O                   
diverticulitis       B-DISEASE            B-DISEASE           
.                    O                    O                   
Clinical             O                    O                   
correlation          O                    O                   
is                   O                    O                   
recommended          O                    O                   
.                    O                    O                   
Given                O                    O                   
the                  O                    O                   
imaging              O                    O                   
findings             O                    O                   
and                  O                    O                   
clinical             O                    O                   
presentation         O                    O                   
,                    O                    O                   
empiric              O                    O                   
treatment            O                    O                   
with                 O                    O                   
hydroxychloroquine   B-MEDICATION         B-MEDICATION        
should               O                    O                   
be                   O                    O                   
considered           O                    O                   
pending              O                    O                   
culture              O                    O                   
results              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 106:
[CLS]                O                    O                   
Assessment           O                    O                   
and                  O                    O                   
Plan                 O                    O                   
:                    O                    O                   
#                    O                    O                   
atrial               B-DISEASE            B-DISEASE           
fibrillation         I-DISEASE            I-DISEASE           
-                    O                    O                   
largely              O                    O                   
controlled           O                    O                   
but                  O                    O                   
recent               O                    O                   
stress               O                    O                   
has                  O                    O                   
caused               O                    O                   
an                   O                    O                   
uptick               O                    O                   
in                   O                    O                   
symptoms             O                    O                   
.                    O                    O                   
We                   O                    O                   
will                 O                    O                   
increase             O                    O                   
the                  O                    O                   
dosage               O                    O                   
of                   O                    O                   
sertraline           B-MEDICATION         B-MEDICATION        
from                 O                    O                   
10mg                 O                    O                   
to                   O                    O                   
20mg                 O                    O                   
daily                O                    O                   
.                    O                    O                   
Patient              O                    O                   
was                  O                    O                   
advised              O                    O                   
to                   O                    O                   
monitor              O                    O                   
for                  O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
#                    O                    O                   
Hypertension         O                    O                   
-                    O                    O                   
stable               O                    O                   
.                    O                    O                   
#                    O                    O                   
Diabetes             O                    O                   
-                    O                    O                   
diet                 O                    O                   
controlled           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 107:
[CLS]                O                    O                   
Radiology            O                    O                   
Report               O                    O                   
:                    O                    O                   
Chest                O                    O                   
X                    O                    O                   
-                    O                    O                   
ray                  O                    O                   
shows                O                    O                   
patchy               O                    O                   
infiltrates          O                    O                   
consistent           O                    O                   
with                 O                    O                   
diverticulitis       B-DISEASE            B-DISEASE           
.                    O                    O                   
Clinical             O                    O                   
correlation          O                    O                   
is                   O                    O                   
recommended          O                    O                   
.                    O                    O                   
Given                O                    O                   
the                  O                    O                   
imaging              O                    O                   
findings             O                    O                   
and                  O                    O                   
clinical             O                    O                   
presentation         O                    O                   
,                    O                    O                   
empiric              O                    O                   
treatment            O                    O                   
with                 O                    O                   
gabapentin           B-MEDICATION         B-MEDICATION        
should               O                    O                   
be                   O                    O                   
considered           O                    O                   
pending              O                    O                   
culture              O                    O                   
results              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 108:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
fentanyl             B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
parkinson            B-DISEASE            I-MEDICATION        
'                    I-DISEASE            I-DISEASE           
s                    I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
fentanyl             B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 109:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
stroke               B-DISEASE            B-DISEASE           
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
hydroxychloroquine   B-MEDICATION         B-MEDICATION        
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
stroke               B-DISEASE            B-DISEASE           
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 110:
[CLS]                O                    O                   
Subjective           O                    O                   
:                    O                    O                   
Patient              O                    O                   
reports              O                    O                   
feeling              O                    O                   
'                    O                    O                   
unwell               O                    O                   
'                    O                    O                   
for                  O                    O                   
3                    O                    O                   
days                 O                    O                   
.                    O                    O                   
History              O                    O                   
of                   O                    O                   
present              O                    O                   
illness              O                    O                   
is                   O                    O                   
consistent           O                    O                   
with                 O                    O                   
a                    O                    O                   
flare                O                    O                   
of                   O                    O                   
atrial               B-DISEASE            B-DISEASE           
fibrillation         I-DISEASE            I-DISEASE           
.                    O                    O                   
She                  O                    O                   
mentions             O                    O                   
she                  O                    O                   
ran                  O                    O                   
out                  O                    O                   
of                   O                    O                   
omeprazole           B-MEDICATION         B-MEDICATION        
4                    O                    O                   
days                 O                    O                   
ago                  O                    O                   
.                    O                    O                   
Objective            O                    O                   
:                    O                    O                   
Vitals               O                    O                   
stable               O                    O                   
.                    O                    O                   
Plan                 O                    O                   
:                    O                    O                   
Restart              O                    O                   
omeprazole           B-MEDICATION         B-MEDICATION        
immediately          O                    O                   
and                  O                    O                   
schedule             O                    O                   
lab                  O                    O                   
work                 O                    O                   
to                   O                    O                   
assess               O                    O                   
specificity          O                    O                   
of                   O                    O                   
atrial               B-DISEASE            B-DISEASE           
fibrillation         I-DISEASE            I-DISEASE           
markers              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 111:
[CLS]                O                    O                   
Dermatology          O                    O                   
consult              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
presents             O                    O                   
with                 O                    O                   
a                    O                    O                   
diffuse              O                    O                   
rash                 O                    O                   
.                    O                    O                   
Differential         O                    O                   
diagnosis            O                    O                   
includes             O                    O                   
drug                 O                    O                   
eruption             O                    O                   
from                 O                    O                   
recent               O                    O                   
initiation           O                    O                   
of                   O                    O                   
jardiance            B-MEDICATION         B-MEDICATION        
versus               O                    O                   
cutanous             O                    O                   
manifestation        O                    O                   
of                   O                    O                   
underlying           O                    O                   
celiac               B-DISEASE            B-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
Biopsy               O                    O                   
performed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 112:
[CLS]                O                    O                   
The                  O                    O                   
62                   O                    O                   
-                    O                    O                   
year                 O                    O                   
-                    O                    O                   
old                  O                    O                   
female               O                    O                   
patient              O                    O                   
with                 O                    O                   
a                    O                    O                   
history              O                    O                   
of                   O                    O                   
stroke               B-DISEASE            B-DISEASE           
returns              O                    O                   
for                  O                    O                   
routine              O                    O                   
follow               O                    O                   
-                    O                    O                   
up                   O                    O                   
.                    O                    O                   
She                  O                    O                   
states               O                    O                   
that                 O                    O                   
the                  O                    O                   
hydroxychloroquine   B-MEDICATION         B-MEDICATION        
prescribed           O                    O                   
at                   O                    O                   
the                  O                    O                   
last                 O                    O                   
visit                O                    O                   
has                  O                    O                   
significantly        O                    O                   
reduced              O                    O                   
her                  O                    O                   
pain                 O                    O                   
levels               O                    O                   
.                    O                    O                   
However              O                    O                   
,                    O                    O                   
she                  O                    O                   
is                   O                    O                   
concerned            O                    O                   
about                O                    O                   
potential            O                    O                   
long                 O                    O                   
-                    O                    O                   
term                 O                    O                   
interactions         O                    O                   
between              O                    O                   
hydroxychloroquine   B-MEDICATION         B-MEDICATION        
and                  O                    O                   
her                  O                    O                   
other                O                    O                   
supplements          O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 113:
[CLS]                O                    O                   
Assessment           O                    O                   
and                  O                    O                   
Plan                 O                    O                   
:                    O                    O                   
#                    O                    O                   
irritable            B-DISEASE            O                   
bowel                I-DISEASE            B-DISEASE           
syndrome             I-DISEASE            O                   
-                    O                    O                   
largely              O                    O                   
controlled           O                    O                   
but                  O                    O                   
recent               O                    O                   
stress               O                    O                   
has                  O                    O                   
caused               O                    O                   
an                   O                    O                   
uptick               O                    O                   
in                   O                    O                   
symptoms             O                    O                   
.                    O                    O                   
We                   O                    O                   
will                 O                    O                   
increase             O                    O                   
the                  O                    O                   
dosage               O                    O                   
of                   O                    O                   
insulin              B-MEDICATION         B-MEDICATION        
glargine             I-MEDICATION         O                   
from                 O                    O                   
10mg                 O                    O                   
to                   O                    O                   
20mg                 O                    O                   
daily                O                    O                   
.                    O                    O                   
Patient              O                    O                   
was                  O                    O                   
advised              O                    O                   
to                   O                    O                   
monitor              O                    O                   
for                  O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
#                    O                    O                   
Hypertension         O                    O                   
-                    O                    O                   
stable               O                    O                   
.                    O                    O                   
#                    O                    O                   
Diabetes             O                    O                   
-                    O                    O                   
diet                 O                    O                   
controlled           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 114:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
omeprazole           B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
migraine             B-DISEASE            B-DISEASE           
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
omeprazole           B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 115:
[CLS]                O                    O                   
The                  O                    O                   
patient              O                    O                   
,                    O                    O                   
a                    O                    O                   
45                   O                    O                   
-                    O                    O                   
year                 O                    O                   
-                    O                    O                   
old                  O                    O                   
male                 O                    O                   
with                 O                    O                   
a                    O                    O                   
significant          O                    O                   
past                 O                    O                   
medical              O                    O                   
history              O                    O                   
of                   O                    O                   
migraine             B-DISEASE            B-DISEASE           
,                    O                    O                   
presented            O                    O                   
to                   O                    O                   
the                  O                    O                   
emergency            O                    O                   
department           O                    O                   
complaining          O                    O                   
of                   O                    O                   
worsening            O                    O                   
fatigue              O                    O                   
and                  O                    O                   
shortness            O                    O                   
of                   O                    O                   
breath               O                    O                   
.                    O                    O                   
Upon                 O                    O                   
review               O                    O                   
of                   O                    O                   
systems              O                    O                   
,                    O                    O                   
he                   O                    O                   
noted                O                    O                   
that                 O                    O                   
he                   O                    O                   
has                  O                    O                   
been                 O                    O                   
non                  O                    O                   
-                    O                    O                   
compliant            O                    O                   
with                 O                    O                   
his                  O                    O                   
home                 O                    O                   
medication           O                    O                   
,                    O                    O                   
hydrochlorothiazide  B-MEDICATION         B-MEDICATION        
,                    O                    O                   
for                  O                    O                   
the                  O                    O                   
past                 O                    O                   
two                  O                    O                   
weeks                O                    O                   
due                  O                    O                   
to                   O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 116:
[CLS]                O                    O                   
Assessment           O                    O                   
and                  O                    O                   
Plan                 O                    O                   
:                    O                    O                   
#                    O                    O                   
lupus                B-DISEASE            O                   
-                    O                    O                   
largely              O                    O                   
controlled           O                    O                   
but                  O                    O                   
recent               O                    O                   
stress               O                    O                   
has                  O                    O                   
caused               O                    O                   
an                   O                    O                   
uptick               O                    O                   
in                   O                    O                   
symptoms             O                    O                   
.                    O                    O                   
We                   O                    O                   
will                 O                    O                   
increase             O                    O                   
the                  O                    O                   
dosage               O                    O                   
of                   O                    O                   
dexamethasone        B-MEDICATION         B-MEDICATION        
from                 O                    O                   
10mg                 O                    O                   
to                   O                    O                   
20mg                 O                    O                   
daily                O                    O                   
.                    O                    O                   
Patient              O                    O                   
was                  O                    O                   
advised              O                    O                   
to                   O                    O                   
monitor              O                    O                   
for                  O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
#                    O                    O                   
Hypertension         O                    O                   
-                    O                    O                   
stable               O                    O                   
.                    O                    O                   
#                    O                    O                   
Diabetes             O                    O                   
-                    O                    O                   
diet                 O                    O                   
controlled           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 117:
[CLS]                O                    O                   
Subjective           O                    O                   
:                    O                    O                   
Patient              O                    O                   
reports              O                    O                   
feeling              O                    O                   
'                    O                    O                   
unwell               O                    O                   
'                    O                    O                   
for                  O                    O                   
3                    O                    O                   
days                 O                    O                   
.                    O                    O                   
History              O                    O                   
of                   O                    O                   
present              O                    O                   
illness              O                    O                   
is                   O                    O                   
consistent           O                    O                   
with                 O                    O                   
a                    O                    O                   
flare                O                    O                   
of                   O                    O                   
hepatitis            B-DISEASE            B-DISEASE           
c                    I-DISEASE            I-DISEASE           
.                    O                    O                   
She                  O                    O                   
mentions             O                    O                   
she                  O                    O                   
ran                  O                    O                   
out                  O                    O                   
of                   O                    O                   
sertraline           B-MEDICATION         B-MEDICATION        
4                    O                    O                   
days                 O                    O                   
ago                  O                    O                   
.                    O                    O                   
Objective            O                    O                   
:                    O                    O                   
Vitals               O                    O                   
stable               O                    O                   
.                    O                    O                   
Plan                 O                    O                   
:                    O                    O                   
Restart              O                    O                   
sertraline           B-MEDICATION         B-MEDICATION        
immediately          O                    O                   
and                  O                    O                   
schedule             O                    O                   
lab                  O                    O                   
work                 O                    O                   
to                   O                    O                   
assess               O                    O                   
specificity          O                    O                   
of                   O                    O                   
hepatitis            B-DISEASE            B-DISEASE           
c                    I-DISEASE            I-DISEASE           
markers              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 118:
[CLS]                O                    O                   
Assessment           O                    O                   
and                  O                    O                   
Plan                 O                    O                   
:                    O                    O                   
#                    O                    O                   
gout                 B-DISEASE            B-DISEASE           
-                    O                    O                   
largely              O                    O                   
controlled           O                    O                   
but                  O                    O                   
recent               O                    O                   
stress               O                    O                   
has                  O                    O                   
caused               O                    O                   
an                   O                    O                   
uptick               O                    O                   
in                   O                    O                   
symptoms             O                    O                   
.                    O                    O                   
We                   O                    O                   
will                 O                    O                   
increase             O                    O                   
the                  O                    O                   
dosage               O                    O                   
of                   O                    O                   
morphine             B-MEDICATION         B-MEDICATION        
from                 O                    O                   
10mg                 O                    O                   
to                   O                    O                   
20mg                 O                    O                   
daily                O                    O                   
.                    O                    O                   
Patient              O                    O                   
was                  O                    O                   
advised              O                    O                   
to                   O                    O                   
monitor              O                    O                   
for                  O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
#                    O                    O                   
Hypertension         O                    O                   
-                    O                    O                   
stable               O                    O                   
.                    O                    O                   
#                    O                    O                   
Diabetes             O                    O                   
-                    O                    O                   
diet                 O                    O                   
controlled           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 119:
[CLS]                O                    O                   
Assessment           O                    O                   
and                  O                    O                   
Plan                 O                    O                   
:                    O                    O                   
#                    O                    O                   
hepatitis            B-DISEASE            B-DISEASE           
c                    I-DISEASE            I-DISEASE           
-                    O                    O                   
largely              O                    O                   
controlled           O                    O                   
but                  O                    O                   
recent               O                    O                   
stress               O                    O                   
has                  O                    O                   
caused               O                    O                   
an                   O                    O                   
uptick               O                    O                   
in                   O                    O                   
symptoms             O                    O                   
.                    O                    O                   
We                   O                    O                   
will                 O                    O                   
increase             O                    O                   
the                  O                    O                   
dosage               O                    O                   
of                   O                    O                   
metformin            B-MEDICATION         B-MEDICATION        
from                 O                    O                   
10mg                 O                    O                   
to                   O                    O                   
20mg                 O                    O                   
daily                O                    O                   
.                    O                    O                   
Patient              O                    O                   
was                  O                    O                   
advised              O                    O                   
to                   O                    O                   
monitor              O                    O                   
for                  O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
#                    O                    O                   
Hypertension         O                    O                   
-                    O                    O                   
stable               O                    O                   
.                    O                    O                   
#                    O                    O                   
Diabetes             O                    O                   
-                    O                    O                   
diet                 O                    O                   
controlled           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 120:
[CLS]                O                    O                   
Assessment           O                    O                   
and                  O                    O                   
Plan                 O                    O                   
:                    O                    O                   
#                    O                    O                   
stroke               B-DISEASE            B-DISEASE           
-                    O                    O                   
largely              O                    O                   
controlled           O                    O                   
but                  O                    O                   
recent               O                    O                   
stress               O                    O                   
has                  O                    O                   
caused               O                    O                   
an                   O                    O                   
uptick               O                    O                   
in                   O                    O                   
symptoms             O                    O                   
.                    O                    O                   
We                   O                    O                   
will                 O                    O                   
increase             O                    O                   
the                  O                    O                   
dosage               O                    O                   
of                   O                    O                   
fluoxetine           B-MEDICATION         B-MEDICATION        
from                 O                    O                   
10mg                 O                    O                   
to                   O                    O                   
20mg                 O                    O                   
daily                O                    O                   
.                    O                    O                   
Patient              O                    O                   
was                  O                    O                   
advised              O                    O                   
to                   O                    O                   
monitor              O                    O                   
for                  O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
#                    O                    O                   
Hypertension         O                    O                   
-                    O                    O                   
stable               O                    O                   
.                    O                    O                   
#                    O                    O                   
Diabetes             O                    O                   
-                    O                    O                   
diet                 O                    O                   
controlled           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 121:
[CLS]                O                    O                   
Subjective           O                    O                   
:                    O                    O                   
Patient              O                    O                   
reports              O                    O                   
feeling              O                    O                   
'                    O                    O                   
unwell               O                    O                   
'                    O                    O                   
for                  O                    O                   
3                    O                    O                   
days                 O                    O                   
.                    O                    O                   
History              O                    O                   
of                   O                    O                   
present              O                    O                   
illness              O                    O                   
is                   O                    O                   
consistent           O                    O                   
with                 O                    O                   
a                    O                    O                   
flare                O                    O                   
of                   O                    O                   
fibromyalgia         B-DISEASE            B-DISEASE           
.                    O                    O                   
She                  O                    O                   
mentions             O                    O                   
she                  O                    O                   
ran                  O                    O                   
out                  O                    O                   
of                   O                    O                   
fluoxetine           B-MEDICATION         B-MEDICATION        
4                    O                    O                   
days                 O                    O                   
ago                  O                    O                   
.                    O                    O                   
Objective            O                    O                   
:                    O                    O                   
Vitals               O                    O                   
stable               O                    O                   
.                    O                    O                   
Plan                 O                    O                   
:                    O                    O                   
Restart              O                    O                   
fluoxetine           B-MEDICATION         B-MEDICATION        
immediately          O                    O                   
and                  O                    O                   
schedule             O                    O                   
lab                  O                    O                   
work                 O                    O                   
to                   O                    O                   
assess               O                    O                   
specificity          O                    O                   
of                   O                    O                   
fibromyalgia         B-DISEASE            B-DISEASE           
markers              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 122:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
tuberculosis         B-DISEASE            O                   
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
sumatriptan          B-MEDICATION         B-MEDICATION        
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
tuberculosis         B-DISEASE            O                   
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 123:
[CLS]                O                    O                   
Dermatology          O                    O                   
consult              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
presents             O                    O                   
with                 O                    O                   
a                    O                    O                   
diffuse              O                    O                   
rash                 O                    O                   
.                    O                    O                   
Differential         O                    O                   
diagnosis            O                    O                   
includes             O                    O                   
drug                 O                    O                   
eruption             O                    O                   
from                 O                    O                   
recent               O                    O                   
initiation           O                    O                   
of                   O                    O                   
lisinopril           B-MEDICATION         B-MEDICATION        
versus               O                    O                   
cutanous             O                    O                   
manifestation        O                    O                   
of                   O                    O                   
underlying           O                    O                   
sarcoidosis          B-DISEASE            B-DISEASE           
.                    O                    O                   
Biopsy               O                    O                   
performed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 124:
[CLS]                O                    O                   
Assessment           O                    O                   
and                  O                    O                   
Plan                 O                    O                   
:                    O                    O                   
#                    O                    O                   
tuberculosis         B-DISEASE            O                   
-                    O                    O                   
largely              O                    O                   
controlled           O                    O                   
but                  O                    O                   
recent               O                    O                   
stress               O                    O                   
has                  O                    O                   
caused               O                    O                   
an                   O                    O                   
uptick               O                    O                   
in                   O                    O                   
symptoms             O                    O                   
.                    O                    O                   
We                   O                    O                   
will                 O                    O                   
increase             O                    O                   
the                  O                    O                   
dosage               O                    O                   
of                   O                    O                   
morphine             B-MEDICATION         B-MEDICATION        
from                 O                    O                   
10mg                 O                    O                   
to                   O                    O                   
20mg                 O                    O                   
daily                O                    O                   
.                    O                    O                   
Patient              O                    O                   
was                  O                    O                   
advised              O                    O                   
to                   O                    O                   
monitor              O                    O                   
for                  O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
#                    O                    O                   
Hypertension         O                    O                   
-                    O                    O                   
stable               O                    O                   
.                    O                    O                   
#                    O                    O                   
Diabetes             O                    O                   
-                    O                    O                   
diet                 O                    O                   
controlled           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 125:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
morphine             B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
coronary             B-DISEASE            O                   
artery               I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
morphine             B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 126:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
methotrexate         B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
sleep                B-DISEASE            B-DISEASE           
apnea                I-DISEASE            I-DISEASE           
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
methotrexate         B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 127:
[CLS]                O                    O                   
The                  O                    O                   
62                   O                    O                   
-                    O                    O                   
year                 O                    O                   
-                    O                    O                   
old                  O                    O                   
female               O                    O                   
patient              O                    O                   
with                 O                    O                   
a                    O                    O                   
history              O                    O                   
of                   O                    O                   
sarcoidosis          B-DISEASE            B-DISEASE           
returns              O                    O                   
for                  O                    O                   
routine              O                    O                   
follow               O                    O                   
-                    O                    O                   
up                   O                    O                   
.                    O                    O                   
She                  O                    O                   
states               O                    O                   
that                 O                    O                   
the                  O                    O                   
fentanyl             B-MEDICATION         B-MEDICATION        
prescribed           O                    O                   
at                   O                    O                   
the                  O                    O                   
last                 O                    O                   
visit                O                    O                   
has                  O                    O                   
significantly        O                    O                   
reduced              O                    O                   
her                  O                    O                   
pain                 O                    O                   
levels               O                    O                   
.                    O                    O                   
However              O                    O                   
,                    O                    O                   
she                  O                    O                   
is                   O                    O                   
concerned            O                    O                   
about                O                    O                   
potential            O                    O                   
long                 O                    O                   
-                    O                    O                   
term                 O                    O                   
interactions         O                    O                   
between              O                    O                   
fentanyl             B-MEDICATION         B-MEDICATION        
and                  O                    O                   
her                  O                    O                   
other                O                    O                   
supplements          O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 128:
[CLS]                O                    O                   
Radiology            O                    O                   
Report               O                    O                   
:                    O                    O                   
Chest                O                    O                   
X                    O                    O                   
-                    O                    O                   
ray                  O                    O                   
shows                O                    O                   
patchy               O                    O                   
infiltrates          O                    O                   
consistent           O                    O                   
with                 O                    O                   
migraine             B-DISEASE            B-DISEASE           
.                    O                    O                   
Clinical             O                    O                   
correlation          O                    O                   
is                   O                    O                   
recommended          O                    O                   
.                    O                    O                   
Given                O                    O                   
the                  O                    O                   
imaging              O                    O                   
findings             O                    O                   
and                  O                    O                   
clinical             O                    O                   
presentation         O                    O                   
,                    O                    O                   
empiric              O                    O                   
treatment            O                    O                   
with                 O                    O                   
lisinopril           B-MEDICATION         B-MEDICATION        
should               O                    O                   
be                   O                    O                   
considered           O                    O                   
pending              O                    O                   
culture              O                    O                   
results              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 129:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
hydroxychloroquine   B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
hepatitis            B-DISEASE            B-DISEASE           
b                    I-DISEASE            O                   
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
hydroxychloroquine   B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 130:
[CLS]                O                    O                   
Discharge            O                    O                   
Summary              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
was                  O                    O                   
admitted             O                    O                   
for                  O                    O                   
an                   O                    O                   
acute                O                    O                   
exacerbation         O                    O                   
of                   O                    O                   
hepatitis            B-DISEASE            B-DISEASE           
c                    I-DISEASE            I-DISEASE           
.                    O                    O                   
During               O                    O                   
the                  O                    O                   
hospital             O                    O                   
stay                 O                    O                   
,                    O                    O                   
symptoms             O                    O                   
were                 O                    O                   
initially            O                    O                   
managed              O                    O                   
with                 O                    O                   
IV                   O                    O                   
fluids               O                    O                   
and                  O                    O                   
subsequently         O                    O                   
transitioned         O                    O                   
to                   O                    O                   
oral                 O                    O                   
sumatriptan          B-MEDICATION         O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
is                   O                    O                   
stable               O                    O                   
for                  O                    O                   
discharge            O                    O                   
and                  O                    O                   
instructed           O                    O                   
to                   O                    O                   
follow               O                    O                   
up                   O                    O                   
with                 O                    O                   
primary              O                    O                   
care                 O                    O                   
for                  O                    O                   
monitoring           O                    O                   
of                   O                    O                   
hepatitis            B-DISEASE            B-DISEASE           
c                    I-DISEASE            I-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 131:
[CLS]                O                    O                   
Emergent             O                    O                   
care                 O                    O                   
note                 O                    O                   
:                    O                    O                   
Patient              O                    O                   
found                O                    O                   
unresponsive         O                    O                   
.                    O                    O                   
Medical              O                    O                   
alert                O                    O                   
bracelet             O                    O                   
indicates            O                    O                   
tuberculosis         B-DISEASE            O                   
.                    O                    O                   
EMS                  O                    O                   
administered         O                    O                   
naloxone             O                    O                   
without              O                    O                   
effect               O                    O                   
.                    O                    O                   
Family               O                    O                   
arrived              O                    O                   
and                  O                    O                   
confirmed            O                    O                   
patient              O                    O                   
takes                O                    O                   
isoniazid            B-MEDICATION         B-MEDICATION        
for                  O                    O                   
the                  O                    O                   
condition            O                    O                   
.                    O                    O                   
Transported          O                    O                   
to                   O                    O                   
ICU                  O                    O                   
for                  O                    O                   
further              O                    O                   
management           O                    O                   
of                   O                    O                   
status               O                    O                   
epilepticus          O                    O                   
secondary            O                    O                   
to                   O                    O                   
tuberculosis         B-DISEASE            O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 132:
[CLS]                O                    O                   
Discharge            O                    O                   
Summary              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
was                  O                    O                   
admitted             O                    O                   
for                  O                    O                   
an                   O                    O                   
acute                O                    O                   
exacerbation         O                    O                   
of                   O                    O                   
parkinson            B-DISEASE            B-MEDICATION        
'                    I-DISEASE            I-DISEASE           
s                    I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
During               O                    O                   
the                  O                    O                   
hospital             O                    O                   
stay                 O                    O                   
,                    O                    O                   
symptoms             O                    O                   
were                 O                    O                   
initially            O                    O                   
managed              O                    O                   
with                 O                    O                   
IV                   O                    O                   
fluids               O                    O                   
and                  O                    O                   
subsequently         O                    O                   
transitioned         O                    O                   
to                   O                    O                   
oral                 O                    O                   
bupropion            B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
is                   O                    O                   
stable               O                    O                   
for                  O                    O                   
discharge            O                    O                   
and                  O                    O                   
instructed           O                    O                   
to                   O                    O                   
follow               O                    O                   
up                   O                    O                   
with                 O                    O                   
primary              O                    O                   
care                 O                    O                   
for                  O                    O                   
monitoring           O                    O                   
of                   O                    O                   
parkinson            B-DISEASE            B-MEDICATION        
'                    I-DISEASE            I-DISEASE           
s                    I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 133:
[CLS]                O                    O                   
Emergent             O                    O                   
care                 O                    O                   
note                 O                    O                   
:                    O                    O                   
Patient              O                    O                   
found                O                    O                   
unresponsive         O                    O                   
.                    O                    O                   
Medical              O                    O                   
alert                O                    O                   
bracelet             O                    O                   
indicates            O                    O                   
atrial               B-DISEASE            B-DISEASE           
fibrillation         I-DISEASE            I-DISEASE           
.                    O                    O                   
EMS                  O                    O                   
administered         O                    O                   
naloxone             O                    O                   
without              O                    O                   
effect               O                    O                   
.                    O                    O                   
Family               O                    O                   
arrived              O                    O                   
and                  O                    O                   
confirmed            O                    O                   
patient              O                    O                   
takes                O                    O                   
morphine             B-MEDICATION         B-MEDICATION        
for                  O                    O                   
the                  O                    O                   
condition            O                    O                   
.                    O                    O                   
Transported          O                    O                   
to                   O                    O                   
ICU                  O                    O                   
for                  O                    O                   
further              O                    O                   
management           O                    O                   
of                   O                    O                   
status               O                    O                   
epilepticus          O                    O                   
secondary            O                    O                   
to                   O                    O                   
atrial               B-DISEASE            B-DISEASE           
fibrillation         I-DISEASE            I-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 134:
[CLS]                O                    O                   
Subjective           O                    O                   
:                    O                    O                   
Patient              O                    O                   
reports              O                    O                   
feeling              O                    O                   
'                    O                    O                   
unwell               O                    O                   
'                    O                    O                   
for                  O                    O                   
3                    O                    O                   
days                 O                    O                   
.                    O                    O                   
History              O                    O                   
of                   O                    O                   
present              O                    O                   
illness              O                    O                   
is                   O                    O                   
consistent           O                    O                   
with                 O                    O                   
a                    O                    O                   
flare                O                    O                   
of                   O                    O                   
migraine             B-DISEASE            B-DISEASE           
.                    O                    O                   
She                  O                    O                   
mentions             O                    O                   
she                  O                    O                   
ran                  O                    O                   
out                  O                    O                   
of                   O                    O                   
ciprofloxacin        B-MEDICATION         B-MEDICATION        
4                    O                    O                   
days                 O                    O                   
ago                  O                    O                   
.                    O                    O                   
Objective            O                    O                   
:                    O                    O                   
Vitals               O                    O                   
stable               O                    O                   
.                    O                    O                   
Plan                 O                    O                   
:                    O                    O                   
Restart              O                    O                   
ciprofloxacin        B-MEDICATION         B-MEDICATION        
immediately          O                    O                   
and                  O                    O                   
schedule             O                    O                   
lab                  O                    O                   
work                 O                    O                   
to                   O                    O                   
assess               O                    O                   
specificity          O                    O                   
of                   O                    O                   
migraine             B-DISEASE            B-DISEASE           
markers              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 135:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
colon                B-DISEASE            B-DISEASE           
cancer               I-DISEASE            I-DISEASE           
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
gabapentin           B-MEDICATION         B-MEDICATION        
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
colon                B-DISEASE            B-DISEASE           
cancer               I-DISEASE            I-DISEASE           
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 136:
[CLS]                O                    O                   
Radiology            O                    O                   
Report               O                    O                   
:                    O                    O                   
Chest                O                    O                   
X                    O                    O                   
-                    O                    O                   
ray                  O                    O                   
shows                O                    O                   
patchy               O                    O                   
infiltrates          O                    O                   
consistent           O                    O                   
with                 O                    O                   
irritable            B-DISEASE            O                   
bowel                I-DISEASE            O                   
syndrome             I-DISEASE            O                   
.                    O                    O                   
Clinical             O                    O                   
correlation          O                    O                   
is                   O                    O                   
recommended          O                    O                   
.                    O                    O                   
Given                O                    O                   
the                  O                    O                   
imaging              O                    O                   
findings             O                    O                   
and                  O                    O                   
clinical             O                    O                   
presentation         O                    O                   
,                    O                    O                   
empiric              O                    O                   
treatment            O                    O                   
with                 O                    O                   
lisinopril           B-MEDICATION         B-MEDICATION        
should               O                    O                   
be                   O                    O                   
considered           O                    O                   
pending              O                    O                   
culture              O                    O                   
results              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 137:
[CLS]                O                    O                   
Radiology            O                    O                   
Report               O                    O                   
:                    O                    O                   
Chest                O                    O                   
X                    O                    O                   
-                    O                    O                   
ray                  O                    O                   
shows                O                    O                   
patchy               O                    O                   
infiltrates          O                    O                   
consistent           O                    O                   
with                 O                    O                   
multiple             B-DISEASE            B-DISEASE           
sclerosis            I-DISEASE            I-DISEASE           
.                    O                    O                   
Clinical             O                    O                   
correlation          O                    O                   
is                   O                    O                   
recommended          O                    O                   
.                    O                    O                   
Given                O                    O                   
the                  O                    O                   
imaging              O                    O                   
findings             O                    O                   
and                  O                    O                   
clinical             O                    O                   
presentation         O                    O                   
,                    O                    O                   
empiric              O                    O                   
treatment            O                    O                   
with                 O                    O                   
atorvastatin         B-MEDICATION         B-MEDICATION        
should               O                    O                   
be                   O                    O                   
considered           O                    O                   
pending              O                    O                   
culture              O                    O                   
results              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 138:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
hydrochlorothiazide  B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
sarcoidosis          B-DISEASE            B-DISEASE           
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
hydrochlorothiazide  B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 139:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
colon                B-DISEASE            B-DISEASE           
cancer               I-DISEASE            I-DISEASE           
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
metformin            B-MEDICATION         B-MEDICATION        
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
colon                B-DISEASE            B-DISEASE           
cancer               I-DISEASE            I-DISEASE           
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 140:
[CLS]                O                    O                   
Emergent             O                    O                   
care                 O                    O                   
note                 O                    O                   
:                    O                    O                   
Patient              O                    O                   
found                O                    O                   
unresponsive         O                    O                   
.                    O                    O                   
Medical              O                    O                   
alert                O                    O                   
bracelet             O                    O                   
indicates            O                    O                   
colon                B-DISEASE            B-DISEASE           
cancer               I-DISEASE            I-DISEASE           
.                    O                    O                   
EMS                  O                    O                   
administered         O                    O                   
naloxone             O                    O                   
without              O                    O                   
effect               O                    O                   
.                    O                    O                   
Family               O                    O                   
arrived              O                    O                   
and                  O                    O                   
confirmed            O                    O                   
patient              O                    O                   
takes                O                    O                   
sertraline           B-MEDICATION         B-MEDICATION        
for                  O                    O                   
the                  O                    O                   
condition            O                    O                   
.                    O                    O                   
Transported          O                    O                   
to                   O                    O                   
ICU                  O                    O                   
for                  O                    O                   
further              O                    O                   
management           O                    O                   
of                   O                    O                   
status               O                    O                   
epilepticus          O                    O                   
secondary            O                    O                   
to                   O                    O                   
colon                B-DISEASE            B-DISEASE           
cancer               I-DISEASE            I-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 141:
[CLS]                O                    O                   
Radiology            O                    O                   
Report               O                    O                   
:                    O                    O                   
Chest                O                    O                   
X                    O                    O                   
-                    O                    O                   
ray                  O                    O                   
shows                O                    O                   
patchy               O                    O                   
infiltrates          O                    O                   
consistent           O                    O                   
with                 O                    O                   
multiple             B-DISEASE            B-DISEASE           
sclerosis            I-DISEASE            I-DISEASE           
.                    O                    O                   
Clinical             O                    O                   
correlation          O                    O                   
is                   O                    O                   
recommended          O                    O                   
.                    O                    O                   
Given                O                    O                   
the                  O                    O                   
imaging              O                    O                   
findings             O                    O                   
and                  O                    O                   
clinical             O                    O                   
presentation         O                    O                   
,                    O                    O                   
empiric              O                    O                   
treatment            O                    O                   
with                 O                    O                   
gluten               B-MEDICATION         O                   
-                    I-MEDICATION         I-MEDICATION        
free                 I-MEDICATION         O                   
diet                 I-MEDICATION         O                   
should               O                    O                   
be                   O                    O                   
considered           O                    O                   
pending              O                    O                   
culture              O                    O                   
results              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 142:
[CLS]                O                    O                   
Emergent             O                    O                   
care                 O                    O                   
note                 O                    O                   
:                    O                    O                   
Patient              O                    O                   
found                O                    O                   
unresponsive         O                    O                   
.                    O                    O                   
Medical              O                    O                   
alert                O                    O                   
bracelet             O                    O                   
indicates            O                    O                   
hepatitis            B-DISEASE            B-DISEASE           
b                    I-DISEASE            O                   
.                    O                    O                   
EMS                  O                    O                   
administered         O                    O                   
naloxone             O                    O                   
without              O                    O                   
effect               O                    O                   
.                    O                    O                   
Family               O                    O                   
arrived              O                    O                   
and                  O                    O                   
confirmed            O                    O                   
patient              O                    O                   
takes                O                    O                   
sertraline           B-MEDICATION         B-MEDICATION        
for                  O                    O                   
the                  O                    O                   
condition            O                    O                   
.                    O                    O                   
Transported          O                    O                   
to                   O                    O                   
ICU                  O                    O                   
for                  O                    O                   
further              O                    O                   
management           O                    O                   
of                   O                    O                   
status               O                    O                   
epilepticus          O                    O                   
secondary            O                    O                   
to                   O                    O                   
hepatitis            B-DISEASE            B-DISEASE           
b                    I-DISEASE            O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 143:
[CLS]                O                    O                   
Subjective           O                    O                   
:                    O                    O                   
Patient              O                    O                   
reports              O                    O                   
feeling              O                    O                   
'                    O                    O                   
unwell               O                    O                   
'                    O                    O                   
for                  O                    O                   
3                    O                    O                   
days                 O                    O                   
.                    O                    O                   
History              O                    O                   
of                   O                    O                   
present              O                    O                   
illness              O                    O                   
is                   O                    O                   
consistent           O                    O                   
with                 O                    O                   
a                    O                    O                   
flare                O                    O                   
of                   O                    O                   
diverticulitis       B-DISEASE            B-DISEASE           
.                    O                    O                   
She                  O                    O                   
mentions             O                    O                   
she                  O                    O                   
ran                  O                    O                   
out                  O                    O                   
of                   O                    O                   
ciprofloxacin        B-MEDICATION         B-MEDICATION        
4                    O                    O                   
days                 O                    O                   
ago                  O                    O                   
.                    O                    O                   
Objective            O                    O                   
:                    O                    O                   
Vitals               O                    O                   
stable               O                    O                   
.                    O                    O                   
Plan                 O                    O                   
:                    O                    O                   
Restart              O                    O                   
ciprofloxacin        B-MEDICATION         B-MEDICATION        
immediately          O                    O                   
and                  O                    O                   
schedule             O                    O                   
lab                  O                    O                   
work                 O                    O                   
to                   O                    O                   
assess               O                    O                   
specificity          O                    O                   
of                   O                    O                   
diverticulitis       B-DISEASE            B-DISEASE           
markers              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 144:
[CLS]                O                    O                   
Emergent             O                    O                   
care                 O                    O                   
note                 O                    O                   
:                    O                    O                   
Patient              O                    O                   
found                O                    O                   
unresponsive         O                    O                   
.                    O                    O                   
Medical              O                    O                   
alert                O                    O                   
bracelet             O                    O                   
indicates            O                    O                   
meningitis           B-DISEASE            B-DISEASE           
.                    O                    O                   
EMS                  O                    O                   
administered         O                    O                   
naloxone             O                    O                   
without              O                    O                   
effect               O                    O                   
.                    O                    O                   
Family               O                    O                   
arrived              O                    O                   
and                  O                    O                   
confirmed            O                    O                   
patient              O                    O                   
takes                O                    O                   
gabapentin           B-MEDICATION         B-MEDICATION        
for                  O                    O                   
the                  O                    O                   
condition            O                    O                   
.                    O                    O                   
Transported          O                    O                   
to                   O                    O                   
ICU                  O                    O                   
for                  O                    O                   
further              O                    O                   
management           O                    O                   
of                   O                    O                   
status               O                    O                   
epilepticus          O                    O                   
secondary            O                    O                   
to                   O                    O                   
meningitis           B-DISEASE            B-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 145:
[CLS]                O                    O                   
Subjective           O                    O                   
:                    O                    O                   
Patient              O                    O                   
reports              O                    O                   
feeling              O                    O                   
'                    O                    O                   
unwell               O                    O                   
'                    O                    O                   
for                  O                    O                   
3                    O                    O                   
days                 O                    O                   
.                    O                    O                   
History              O                    O                   
of                   O                    O                   
present              O                    O                   
illness              O                    O                   
is                   O                    O                   
consistent           O                    O                   
with                 O                    O                   
a                    O                    O                   
flare                O                    O                   
of                   O                    O                   
gout                 B-DISEASE            B-DISEASE           
.                    O                    O                   
She                  O                    O                   
mentions             O                    O                   
she                  O                    O                   
ran                  O                    O                   
out                  O                    O                   
of                   O                    O                   
ciprofloxacin        B-MEDICATION         B-MEDICATION        
4                    O                    O                   
days                 O                    O                   
ago                  O                    O                   
.                    O                    O                   
Objective            O                    O                   
:                    O                    O                   
Vitals               O                    O                   
stable               O                    O                   
.                    O                    O                   
Plan                 O                    O                   
:                    O                    O                   
Restart              O                    O                   
ciprofloxacin        B-MEDICATION         B-MEDICATION        
immediately          O                    O                   
and                  O                    O                   
schedule             O                    O                   
lab                  O                    O                   
work                 O                    O                   
to                   O                    O                   
assess               O                    O                   
specificity          O                    O                   
of                   O                    O                   
gout                 B-DISEASE            B-DISEASE           
markers              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 146:
[CLS]                O                    O                   
Subjective           O                    O                   
:                    O                    O                   
Patient              O                    O                   
reports              O                    O                   
feeling              O                    O                   
'                    O                    O                   
unwell               O                    O                   
'                    O                    O                   
for                  O                    O                   
3                    O                    O                   
days                 O                    O                   
.                    O                    O                   
History              O                    O                   
of                   O                    O                   
present              O                    O                   
illness              O                    O                   
is                   O                    O                   
consistent           O                    O                   
with                 O                    O                   
a                    O                    O                   
flare                O                    O                   
of                   O                    O                   
glaucoma             B-DISEASE            B-DISEASE           
.                    O                    O                   
She                  O                    O                   
mentions             O                    O                   
she                  O                    O                   
ran                  O                    O                   
out                  O                    O                   
of                   O                    O                   
gabapentin           B-MEDICATION         B-MEDICATION        
4                    O                    O                   
days                 O                    O                   
ago                  O                    O                   
.                    O                    O                   
Objective            O                    O                   
:                    O                    O                   
Vitals               O                    O                   
stable               O                    O                   
.                    O                    O                   
Plan                 O                    O                   
:                    O                    O                   
Restart              O                    O                   
gabapentin           B-MEDICATION         B-MEDICATION        
immediately          O                    O                   
and                  O                    O                   
schedule             O                    O                   
lab                  O                    O                   
work                 O                    O                   
to                   O                    O                   
assess               O                    O                   
specificity          O                    O                   
of                   O                    O                   
glaucoma             B-DISEASE            B-DISEASE           
markers              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 147:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
glaucoma             B-DISEASE            B-DISEASE           
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
ibuprofen            B-MEDICATION         B-MEDICATION        
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
glaucoma             B-DISEASE            B-DISEASE           
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 148:
[CLS]                O                    O                   
Radiology            O                    O                   
Report               O                    O                   
:                    O                    O                   
Chest                O                    O                   
X                    O                    O                   
-                    O                    O                   
ray                  O                    O                   
shows                O                    O                   
patchy               O                    O                   
infiltrates          O                    O                   
consistent           O                    O                   
with                 O                    O                   
meningitis           B-DISEASE            B-DISEASE           
.                    O                    O                   
Clinical             O                    O                   
correlation          O                    O                   
is                   O                    O                   
recommended          O                    O                   
.                    O                    O                   
Given                O                    O                   
the                  O                    O                   
imaging              O                    O                   
findings             O                    O                   
and                  O                    O                   
clinical             O                    O                   
presentation         O                    O                   
,                    O                    O                   
empiric              O                    O                   
treatment            O                    O                   
with                 O                    O                   
dexamethasone        B-MEDICATION         B-MEDICATION        
should               O                    O                   
be                   O                    O                   
considered           O                    O                   
pending              O                    O                   
culture              O                    O                   
results              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 149:
[CLS]                O                    O                   
Discharge            O                    O                   
Summary              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
was                  O                    O                   
admitted             O                    O                   
for                  O                    O                   
an                   O                    O                   
acute                O                    O                   
exacerbation         O                    O                   
of                   O                    O                   
osteoporosis         B-DISEASE            B-DISEASE           
.                    O                    O                   
During               O                    O                   
the                  O                    O                   
hospital             O                    O                   
stay                 O                    O                   
,                    O                    O                   
symptoms             O                    O                   
were                 O                    O                   
initially            O                    O                   
managed              O                    O                   
with                 O                    O                   
IV                   O                    O                   
fluids               O                    O                   
and                  O                    O                   
subsequently         O                    O                   
transitioned         O                    O                   
to                   O                    O                   
oral                 O                    O                   
isoniazid            B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
is                   O                    O                   
stable               O                    O                   
for                  O                    O                   
discharge            O                    O                   
and                  O                    O                   
instructed           O                    O                   
to                   O                    O                   
follow               O                    O                   
up                   O                    O                   
with                 O                    O                   
primary              O                    O                   
care                 O                    O                   
for                  O                    O                   
monitoring           O                    O                   
of                   O                    O                   
osteoporosis         B-DISEASE            B-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 150:
[CLS]                O                    O                   
Discharge            O                    O                   
Summary              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
was                  O                    O                   
admitted             O                    O                   
for                  O                    O                   
an                   O                    O                   
acute                O                    O                   
exacerbation         O                    O                   
of                   O                    O                   
migraine             B-DISEASE            B-DISEASE           
.                    O                    O                   
During               O                    O                   
the                  O                    O                   
hospital             O                    O                   
stay                 O                    O                   
,                    O                    O                   
symptoms             O                    O                   
were                 O                    O                   
initially            O                    O                   
managed              O                    O                   
with                 O                    O                   
IV                   O                    O                   
fluids               O                    O                   
and                  O                    O                   
subsequently         O                    O                   
transitioned         O                    O                   
to                   O                    O                   
oral                 O                    O                   
methotrexate         B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
is                   O                    O                   
stable               O                    O                   
for                  O                    O                   
discharge            O                    O                   
and                  O                    O                   
instructed           O                    O                   
to                   O                    O                   
follow               O                    O                   
up                   O                    O                   
with                 O                    O                   
primary              O                    O                   
care                 O                    O                   
for                  O                    O                   
monitoring           O                    O                   
of                   O                    O                   
migraine             B-DISEASE            B-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 151:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
albuterol            B-MEDICATION         O                   
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
celiac               B-DISEASE            B-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
albuterol            B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 152:
[CLS]                O                    O                   
Emergent             O                    O                   
care                 O                    O                   
note                 O                    O                   
:                    O                    O                   
Patient              O                    O                   
found                O                    O                   
unresponsive         O                    O                   
.                    O                    O                   
Medical              O                    O                   
alert                O                    O                   
bracelet             O                    O                   
indicates            O                    O                   
vertigo              B-DISEASE            B-DISEASE           
.                    O                    O                   
EMS                  O                    O                   
administered         O                    O                   
naloxone             O                    O                   
without              O                    O                   
effect               O                    O                   
.                    O                    O                   
Family               O                    O                   
arrived              O                    O                   
and                  O                    O                   
confirmed            O                    O                   
patient              O                    O                   
takes                O                    O                   
eliquis              B-MEDICATION         B-MEDICATION        
for                  O                    O                   
the                  O                    O                   
condition            O                    O                   
.                    O                    O                   
Transported          O                    O                   
to                   O                    O                   
ICU                  O                    O                   
for                  O                    O                   
further              O                    O                   
management           O                    O                   
of                   O                    O                   
status               O                    O                   
epilepticus          O                    O                   
secondary            O                    O                   
to                   O                    O                   
vertigo              B-DISEASE            B-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 153:
[CLS]                O                    O                   
Dermatology          O                    O                   
consult              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
presents             O                    O                   
with                 O                    O                   
a                    O                    O                   
diffuse              O                    O                   
rash                 O                    O                   
.                    O                    O                   
Differential         O                    O                   
diagnosis            O                    O                   
includes             O                    O                   
drug                 O                    O                   
eruption             O                    O                   
from                 O                    O                   
recent               O                    O                   
initiation           O                    O                   
of                   O                    O                   
insulin              B-MEDICATION         B-MEDICATION        
glargine             I-MEDICATION         O                   
versus               O                    O                   
cutanous             O                    O                   
manifestation        O                    O                   
of                   O                    O                   
underlying           O                    O                   
epilepsy             B-DISEASE            B-DISEASE           
.                    O                    O                   
Biopsy               O                    O                   
performed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 154:
[CLS]                O                    O                   
The                  O                    O                   
62                   O                    O                   
-                    O                    O                   
year                 O                    O                   
-                    O                    O                   
old                  O                    O                   
female               O                    O                   
patient              O                    O                   
with                 O                    O                   
a                    O                    O                   
history              O                    O                   
of                   O                    O                   
colon                B-DISEASE            B-DISEASE           
cancer               I-DISEASE            I-DISEASE           
returns              O                    O                   
for                  O                    O                   
routine              O                    O                   
follow               O                    O                   
-                    O                    O                   
up                   O                    O                   
.                    O                    O                   
She                  O                    O                   
states               O                    O                   
that                 O                    O                   
the                  O                    O                   
carbamazepine        B-MEDICATION         B-MEDICATION        
prescribed           O                    O                   
at                   O                    O                   
the                  O                    O                   
last                 O                    O                   
visit                O                    O                   
has                  O                    O                   
significantly        O                    O                   
reduced              O                    O                   
her                  O                    O                   
pain                 O                    O                   
levels               O                    O                   
.                    O                    O                   
However              O                    O                   
,                    O                    O                   
she                  O                    O                   
is                   O                    O                   
concerned            O                    O                   
about                O                    O                   
potential            O                    O                   
long                 O                    O                   
-                    O                    O                   
term                 O                    O                   
interactions         O                    O                   
between              O                    O                   
carbamazepine        B-MEDICATION         B-MEDICATION        
and                  O                    O                   
her                  O                    O                   
other                O                    O                   
supplements          O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 155:
[CLS]                O                    O                   
Assessment           O                    O                   
and                  O                    O                   
Plan                 O                    O                   
:                    O                    O                   
#                    O                    O                   
gout                 B-DISEASE            B-DISEASE           
-                    O                    O                   
largely              O                    O                   
controlled           O                    O                   
but                  O                    O                   
recent               O                    O                   
stress               O                    O                   
has                  O                    O                   
caused               O                    O                   
an                   O                    O                   
uptick               O                    O                   
in                   O                    O                   
symptoms             O                    O                   
.                    O                    O                   
We                   O                    O                   
will                 O                    O                   
increase             O                    O                   
the                  O                    O                   
dosage               O                    O                   
of                   O                    O                   
eliquis              B-MEDICATION         B-MEDICATION        
from                 O                    O                   
10mg                 O                    O                   
to                   O                    O                   
20mg                 O                    O                   
daily                O                    O                   
.                    O                    O                   
Patient              O                    O                   
was                  O                    O                   
advised              O                    O                   
to                   O                    O                   
monitor              O                    O                   
for                  O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
#                    O                    O                   
Hypertension         O                    O                   
-                    O                    O                   
stable               O                    O                   
.                    O                    O                   
#                    O                    O                   
Diabetes             O                    O                   
-                    O                    O                   
diet                 O                    O                   
controlled           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 156:
[CLS]                O                    O                   
The                  O                    O                   
62                   O                    O                   
-                    O                    O                   
year                 O                    O                   
-                    O                    O                   
old                  O                    O                   
female               O                    O                   
patient              O                    O                   
with                 O                    O                   
a                    O                    O                   
history              O                    O                   
of                   O                    O                   
anemia               B-DISEASE            B-DISEASE           
returns              O                    O                   
for                  O                    O                   
routine              O                    O                   
follow               O                    O                   
-                    O                    O                   
up                   O                    O                   
.                    O                    O                   
She                  O                    O                   
states               O                    O                   
that                 O                    O                   
the                  O                    O                   
dexamethasone        B-MEDICATION         B-MEDICATION        
prescribed           O                    O                   
at                   O                    O                   
the                  O                    O                   
last                 O                    O                   
visit                O                    O                   
has                  O                    O                   
significantly        O                    O                   
reduced              O                    O                   
her                  O                    O                   
pain                 O                    O                   
levels               O                    O                   
.                    O                    O                   
However              O                    O                   
,                    O                    O                   
she                  O                    O                   
is                   O                    O                   
concerned            O                    O                   
about                O                    O                   
potential            O                    O                   
long                 O                    O                   
-                    O                    O                   
term                 O                    O                   
interactions         O                    O                   
between              O                    O                   
dexamethasone        B-MEDICATION         B-MEDICATION        
and                  O                    O                   
her                  O                    O                   
other                O                    O                   
supplements          O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 157:
[CLS]                O                    O                   
Radiology            O                    O                   
Report               O                    O                   
:                    O                    O                   
Chest                O                    O                   
X                    O                    O                   
-                    O                    O                   
ray                  O                    O                   
shows                O                    O                   
patchy               O                    O                   
infiltrates          O                    O                   
consistent           O                    O                   
with                 O                    O                   
celiac               B-DISEASE            B-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
Clinical             O                    O                   
correlation          O                    O                   
is                   O                    O                   
recommended          O                    O                   
.                    O                    O                   
Given                O                    O                   
the                  O                    O                   
imaging              O                    O                   
findings             O                    O                   
and                  O                    O                   
clinical             O                    O                   
presentation         O                    O                   
,                    O                    O                   
empiric              O                    O                   
treatment            O                    O                   
with                 O                    O                   
gluten               B-MEDICATION         O                   
-                    I-MEDICATION         I-MEDICATION        
free                 I-MEDICATION         O                   
diet                 I-MEDICATION         O                   
should               O                    O                   
be                   O                    O                   
considered           O                    O                   
pending              O                    O                   
culture              O                    O                   
results              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 158:
[CLS]                O                    O                   
Subjective           O                    O                   
:                    O                    O                   
Patient              O                    O                   
reports              O                    O                   
feeling              O                    O                   
'                    O                    O                   
unwell               O                    O                   
'                    O                    O                   
for                  O                    O                   
3                    O                    O                   
days                 O                    O                   
.                    O                    O                   
History              O                    O                   
of                   O                    O                   
present              O                    O                   
illness              O                    O                   
is                   O                    O                   
consistent           O                    O                   
with                 O                    O                   
a                    O                    O                   
flare                O                    O                   
of                   O                    O                   
coronary             B-DISEASE            O                   
artery               I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
She                  O                    O                   
mentions             O                    O                   
she                  O                    O                   
ran                  O                    O                   
out                  O                    O                   
of                   O                    O                   
amoxicillin          B-MEDICATION         B-MEDICATION        
4                    O                    O                   
days                 O                    O                   
ago                  O                    O                   
.                    O                    O                   
Objective            O                    O                   
:                    O                    O                   
Vitals               O                    O                   
stable               O                    O                   
.                    O                    O                   
Plan                 O                    O                   
:                    O                    O                   
Restart              O                    O                   
amoxicillin          B-MEDICATION         B-MEDICATION        
immediately          O                    O                   
and                  O                    O                   
schedule             O                    O                   
lab                  O                    O                   
work                 O                    O                   
to                   O                    O                   
assess               O                    O                   
specificity          O                    O                   
of                   O                    O                   
coronary             B-DISEASE            I-DISEASE           
artery               I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
markers              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 159:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
gout                 B-DISEASE            B-DISEASE           
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
amoxicillin          B-MEDICATION         B-MEDICATION        
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
gout                 B-DISEASE            B-DISEASE           
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 160:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
amoxicillin          B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
parkinson            B-DISEASE            B-MEDICATION        
'                    I-DISEASE            I-DISEASE           
s                    I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
amoxicillin          B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 161:
[CLS]                O                    O                   
The                  O                    O                   
patient              O                    O                   
,                    O                    O                   
a                    O                    O                   
45                   O                    O                   
-                    O                    O                   
year                 O                    O                   
-                    O                    O                   
old                  O                    O                   
male                 O                    O                   
with                 O                    O                   
a                    O                    O                   
significant          O                    O                   
past                 O                    O                   
medical              O                    O                   
history              O                    O                   
of                   O                    O                   
glaucoma             B-DISEASE            B-DISEASE           
,                    O                    O                   
presented            O                    O                   
to                   O                    O                   
the                  O                    O                   
emergency            O                    O                   
department           O                    O                   
complaining          O                    O                   
of                   O                    O                   
worsening            O                    O                   
fatigue              O                    O                   
and                  O                    O                   
shortness            O                    O                   
of                   O                    O                   
breath               O                    O                   
.                    O                    O                   
Upon                 O                    O                   
review               O                    O                   
of                   O                    O                   
systems              O                    O                   
,                    O                    O                   
he                   O                    O                   
noted                O                    O                   
that                 O                    O                   
he                   O                    O                   
has                  O                    O                   
been                 O                    O                   
non                  O                    O                   
-                    O                    O                   
compliant            O                    O                   
with                 O                    O                   
his                  O                    O                   
home                 O                    O                   
medication           O                    O                   
,                    O                    O                   
omeprazole           B-MEDICATION         B-MEDICATION        
,                    O                    O                   
for                  O                    O                   
the                  O                    O                   
past                 O                    O                   
two                  O                    O                   
weeks                O                    O                   
due                  O                    O                   
to                   O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 162:
[CLS]                O                    O                   
Radiology            O                    O                   
Report               O                    O                   
:                    O                    O                   
Chest                O                    O                   
X                    O                    O                   
-                    O                    O                   
ray                  O                    O                   
shows                O                    O                   
patchy               O                    O                   
infiltrates          O                    O                   
consistent           O                    O                   
with                 O                    O                   
coronary             B-DISEASE            O                   
artery               I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
Clinical             O                    O                   
correlation          O                    O                   
is                   O                    O                   
recommended          O                    O                   
.                    O                    O                   
Given                O                    O                   
the                  O                    O                   
imaging              O                    O                   
findings             O                    O                   
and                  O                    O                   
clinical             O                    O                   
presentation         O                    O                   
,                    O                    O                   
empiric              O                    O                   
treatment            O                    O                   
with                 O                    O                   
metoprolol           B-MEDICATION         B-MEDICATION        
should               O                    O                   
be                   O                    O                   
considered           O                    O                   
pending              O                    O                   
culture              O                    O                   
results              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 163:
[CLS]                O                    O                   
Radiology            O                    O                   
Report               O                    O                   
:                    O                    O                   
Chest                O                    O                   
X                    O                    O                   
-                    O                    O                   
ray                  O                    O                   
shows                O                    O                   
patchy               O                    O                   
infiltrates          O                    O                   
consistent           O                    O                   
with                 O                    O                   
osteoporosis         B-DISEASE            B-DISEASE           
.                    O                    O                   
Clinical             O                    O                   
correlation          O                    O                   
is                   O                    O                   
recommended          O                    O                   
.                    O                    O                   
Given                O                    O                   
the                  O                    O                   
imaging              O                    O                   
findings             O                    O                   
and                  O                    O                   
clinical             O                    O                   
presentation         O                    O                   
,                    O                    O                   
empiric              O                    O                   
treatment            O                    O                   
with                 O                    O                   
metformin            B-MEDICATION         B-MEDICATION        
should               O                    O                   
be                   O                    O                   
considered           O                    O                   
pending              O                    O                   
culture              O                    O                   
results              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 164:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
sarcoidosis          B-DISEASE            B-DISEASE           
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
lisinopril           B-MEDICATION         B-MEDICATION        
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
sarcoidosis          B-DISEASE            B-DISEASE           
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 165:
[CLS]                O                    O                   
Emergent             O                    O                   
care                 O                    O                   
note                 O                    O                   
:                    O                    O                   
Patient              O                    O                   
found                O                    O                   
unresponsive         O                    O                   
.                    O                    O                   
Medical              O                    O                   
alert                O                    O                   
bracelet             O                    O                   
indicates            O                    O                   
meningitis           B-DISEASE            B-DISEASE           
.                    O                    O                   
EMS                  O                    O                   
administered         O                    O                   
naloxone             O                    O                   
without              O                    O                   
effect               O                    O                   
.                    O                    O                   
Family               O                    O                   
arrived              O                    O                   
and                  O                    O                   
confirmed            O                    O                   
patient              O                    O                   
takes                O                    O                   
ciprofloxacin        B-MEDICATION         B-MEDICATION        
for                  O                    O                   
the                  O                    O                   
condition            O                    O                   
.                    O                    O                   
Transported          O                    O                   
to                   O                    O                   
ICU                  O                    O                   
for                  O                    O                   
further              O                    O                   
management           O                    O                   
of                   O                    O                   
status               O                    O                   
epilepticus          O                    O                   
secondary            O                    O                   
to                   O                    O                   
meningitis           B-DISEASE            B-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 166:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
irritable            B-DISEASE            I-DISEASE           
bowel                I-DISEASE            B-DISEASE           
syndrome             I-DISEASE            O                   
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
methotrexate         B-MEDICATION         B-MEDICATION        
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
irritable            B-DISEASE            I-DISEASE           
bowel                I-DISEASE            O                   
syndrome             I-DISEASE            O                   
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 167:
[CLS]                O                    O                   
Radiology            O                    O                   
Report               O                    O                   
:                    O                    O                   
Chest                O                    O                   
X                    O                    O                   
-                    O                    O                   
ray                  O                    O                   
shows                O                    O                   
patchy               O                    O                   
infiltrates          O                    O                   
consistent           O                    O                   
with                 O                    O                   
alzheimer            B-DISEASE            B-DISEASE           
'                    I-DISEASE            I-DISEASE           
s                    I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
Clinical             O                    O                   
correlation          O                    O                   
is                   O                    O                   
recommended          O                    O                   
.                    O                    O                   
Given                O                    O                   
the                  O                    O                   
imaging              O                    O                   
findings             O                    O                   
and                  O                    O                   
clinical             O                    O                   
presentation         O                    O                   
,                    O                    O                   
empiric              O                    O                   
treatment            O                    O                   
with                 O                    O                   
omeprazole           B-MEDICATION         B-MEDICATION        
should               O                    O                   
be                   O                    O                   
considered           O                    O                   
pending              O                    O                   
culture              O                    O                   
results              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 168:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
xarelto              B-MEDICATION         O                   
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
stroke               B-DISEASE            B-DISEASE           
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
xarelto              B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 169:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
carbamazepine        B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
tuberculosis         B-DISEASE            O                   
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
carbamazepine        B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 170:
[CLS]                O                    O                   
Dermatology          O                    O                   
consult              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
presents             O                    O                   
with                 O                    O                   
a                    O                    O                   
diffuse              O                    O                   
rash                 O                    O                   
.                    O                    O                   
Differential         O                    O                   
diagnosis            O                    O                   
includes             O                    O                   
drug                 O                    O                   
eruption             O                    O                   
from                 O                    O                   
recent               O                    O                   
initiation           O                    O                   
of                   O                    O                   
morphine             B-MEDICATION         B-MEDICATION        
versus               O                    O                   
cutanous             O                    O                   
manifestation        O                    O                   
of                   O                    O                   
underlying           O                    O                   
atrial               B-DISEASE            B-DISEASE           
fibrillation         I-DISEASE            I-DISEASE           
.                    O                    O                   
Biopsy               O                    O                   
performed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 171:
[CLS]                O                    O                   
Emergent             O                    O                   
care                 O                    O                   
note                 O                    O                   
:                    O                    O                   
Patient              O                    O                   
found                O                    O                   
unresponsive         O                    O                   
.                    O                    O                   
Medical              O                    O                   
alert                O                    O                   
bracelet             O                    O                   
indicates            O                    O                   
vertigo              B-DISEASE            B-DISEASE           
.                    O                    O                   
EMS                  O                    O                   
administered         O                    O                   
naloxone             O                    O                   
without              O                    O                   
effect               O                    O                   
.                    O                    O                   
Family               O                    O                   
arrived              O                    O                   
and                  O                    O                   
confirmed            O                    O                   
patient              O                    O                   
takes                O                    O                   
gabapentin           B-MEDICATION         B-MEDICATION        
for                  O                    O                   
the                  O                    O                   
condition            O                    O                   
.                    O                    O                   
Transported          O                    O                   
to                   O                    O                   
ICU                  O                    O                   
for                  O                    O                   
further              O                    O                   
management           O                    O                   
of                   O                    O                   
status               O                    O                   
epilepticus          O                    O                   
secondary            O                    O                   
to                   O                    O                   
vertigo              B-DISEASE            B-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 172:
[CLS]                O                    O                   
Subjective           O                    O                   
:                    O                    O                   
Patient              O                    O                   
reports              O                    O                   
feeling              O                    O                   
'                    O                    O                   
unwell               O                    O                   
'                    O                    O                   
for                  O                    O                   
3                    O                    O                   
days                 O                    O                   
.                    O                    O                   
History              O                    O                   
of                   O                    O                   
present              O                    O                   
illness              O                    O                   
is                   O                    O                   
consistent           O                    O                   
with                 O                    O                   
a                    O                    O                   
flare                O                    O                   
of                   O                    O                   
multiple             B-DISEASE            B-DISEASE           
sclerosis            I-DISEASE            I-DISEASE           
.                    O                    O                   
She                  O                    O                   
mentions             O                    O                   
she                  O                    O                   
ran                  O                    O                   
out                  O                    O                   
of                   O                    O                   
sertraline           B-MEDICATION         B-MEDICATION        
4                    O                    O                   
days                 O                    O                   
ago                  O                    O                   
.                    O                    O                   
Objective            O                    O                   
:                    O                    O                   
Vitals               O                    O                   
stable               O                    O                   
.                    O                    O                   
Plan                 O                    O                   
:                    O                    O                   
Restart              O                    O                   
sertraline           B-MEDICATION         B-MEDICATION        
immediately          O                    O                   
and                  O                    O                   
schedule             O                    O                   
lab                  O                    O                   
work                 O                    O                   
to                   O                    O                   
assess               O                    O                   
specificity          O                    O                   
of                   O                    O                   
multiple             B-DISEASE            B-DISEASE           
sclerosis            I-DISEASE            I-DISEASE           
markers              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 173:
[CLS]                O                    O                   
Emergent             O                    O                   
care                 O                    O                   
note                 O                    O                   
:                    O                    O                   
Patient              O                    O                   
found                O                    O                   
unresponsive         O                    O                   
.                    O                    O                   
Medical              O                    O                   
alert                O                    O                   
bracelet             O                    O                   
indicates            O                    O                   
sleep                B-DISEASE            B-DISEASE           
apnea                I-DISEASE            I-DISEASE           
.                    O                    O                   
EMS                  O                    O                   
administered         O                    O                   
naloxone             O                    O                   
without              O                    O                   
effect               O                    O                   
.                    O                    O                   
Family               O                    O                   
arrived              O                    O                   
and                  O                    O                   
confirmed            O                    O                   
patient              O                    O                   
takes                O                    O                   
jardiance            B-MEDICATION         B-MEDICATION        
for                  O                    O                   
the                  O                    O                   
condition            O                    O                   
.                    O                    O                   
Transported          O                    O                   
to                   O                    O                   
ICU                  O                    O                   
for                  O                    O                   
further              O                    O                   
management           O                    O                   
of                   O                    O                   
status               O                    O                   
epilepticus          O                    O                   
secondary            O                    O                   
to                   O                    O                   
sleep                B-DISEASE            B-DISEASE           
apnea                I-DISEASE            I-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 174:
[CLS]                O                    O                   
Discharge            O                    O                   
Summary              O                    O                   
:                    O                    O                   
The                  O                    O                   
patient              O                    O                   
was                  O                    O                   
admitted             O                    O                   
for                  O                    O                   
an                   O                    O                   
acute                O                    O                   
exacerbation         O                    O                   
of                   O                    O                   
colon                B-DISEASE            B-DISEASE           
cancer               I-DISEASE            I-DISEASE           
.                    O                    O                   
During               O                    O                   
the                  O                    O                   
hospital             O                    O                   
stay                 O                    O                   
,                    O                    O                   
symptoms             O                    O                   
were                 O                    O                   
initially            O                    O                   
managed              O                    O                   
with                 O                    O                   
IV                   O                    O                   
fluids               O                    O                   
and                  O                    O                   
subsequently         O                    O                   
transitioned         O                    O                   
to                   O                    O                   
oral                 O                    O                   
hydroxychloroquine   B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
is                   O                    O                   
stable               O                    O                   
for                  O                    O                   
discharge            O                    O                   
and                  O                    O                   
instructed           O                    O                   
to                   O                    O                   
follow               O                    O                   
up                   O                    O                   
with                 O                    O                   
primary              O                    O                   
care                 O                    O                   
for                  O                    O                   
monitoring           O                    O                   
of                   O                    O                   
colon                B-DISEASE            B-DISEASE           
cancer               I-DISEASE            I-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 175:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
coronary             B-DISEASE            B-DISEASE           
artery               I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
fluoxetine           B-MEDICATION         B-MEDICATION        
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
coronary             B-DISEASE            O                   
artery               I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 176:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
gabapentin           B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
irritable            B-DISEASE            O                   
bowel                I-DISEASE            B-DISEASE           
syndrome             I-DISEASE            O                   
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
gabapentin           B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 177:
[CLS]                O                    O                   
Subjective           O                    O                   
:                    O                    O                   
Patient              O                    O                   
reports              O                    O                   
feeling              O                    O                   
'                    O                    O                   
unwell               O                    O                   
'                    O                    O                   
for                  O                    O                   
3                    O                    O                   
days                 O                    O                   
.                    O                    O                   
History              O                    O                   
of                   O                    O                   
present              O                    O                   
illness              O                    O                   
is                   O                    O                   
consistent           O                    O                   
with                 O                    O                   
a                    O                    O                   
flare                O                    O                   
of                   O                    O                   
vertigo              B-DISEASE            B-DISEASE           
.                    O                    O                   
She                  O                    O                   
mentions             O                    O                   
she                  O                    O                   
ran                  O                    O                   
out                  O                    O                   
of                   O                    O                   
hydrochlorothiazide  B-MEDICATION         B-MEDICATION        
4                    O                    O                   
days                 O                    O                   
ago                  O                    O                   
.                    O                    O                   
Objective            O                    O                   
:                    O                    O                   
Vitals               O                    O                   
stable               O                    O                   
.                    O                    O                   
Plan                 O                    O                   
:                    O                    O                   
Restart              O                    O                   
hydrochlorothiazide  B-MEDICATION         B-MEDICATION        
immediately          O                    O                   
and                  O                    O                   
schedule             O                    O                   
lab                  O                    O                   
work                 O                    O                   
to                   O                    O                   
assess               O                    O                   
specificity          O                    O                   
of                   O                    O                   
vertigo              B-DISEASE            B-DISEASE           
markers              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 178:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
morphine             B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
gout                 B-DISEASE            B-DISEASE           
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
morphine             B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 179:
[CLS]                O                    O                   
Subjective           O                    O                   
:                    O                    O                   
Patient              O                    O                   
reports              O                    O                   
feeling              O                    O                   
'                    O                    O                   
unwell               O                    O                   
'                    O                    O                   
for                  O                    O                   
3                    O                    O                   
days                 O                    O                   
.                    O                    O                   
History              O                    O                   
of                   O                    O                   
present              O                    O                   
illness              O                    O                   
is                   O                    O                   
consistent           O                    O                   
with                 O                    O                   
a                    O                    O                   
flare                O                    O                   
of                   O                    O                   
sleep                B-DISEASE            B-DISEASE           
apnea                I-DISEASE            I-DISEASE           
.                    O                    O                   
She                  O                    O                   
mentions             O                    O                   
she                  O                    O                   
ran                  O                    O                   
out                  O                    O                   
of                   O                    O                   
lisinopril           B-MEDICATION         B-MEDICATION        
4                    O                    O                   
days                 O                    O                   
ago                  O                    O                   
.                    O                    O                   
Objective            O                    O                   
:                    O                    O                   
Vitals               O                    O                   
stable               O                    O                   
.                    O                    O                   
Plan                 O                    O                   
:                    O                    O                   
Restart              O                    O                   
lisinopril           B-MEDICATION         B-MEDICATION        
immediately          O                    O                   
and                  O                    O                   
schedule             O                    O                   
lab                  O                    O                   
work                 O                    O                   
to                   O                    O                   
assess               O                    O                   
specificity          O                    O                   
of                   O                    O                   
sleep                B-DISEASE            B-DISEASE           
apnea                I-DISEASE            I-DISEASE           
markers              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 180:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
hepatitis            B-DISEASE            B-DISEASE           
c                    I-DISEASE            I-DISEASE           
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
isoniazid            B-MEDICATION         B-MEDICATION        
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
hepatitis            B-DISEASE            B-DISEASE           
c                    I-DISEASE            I-DISEASE           
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 181:
[CLS]                O                    O                   
Subjective           O                    O                   
:                    O                    O                   
Patient              O                    O                   
reports              O                    O                   
feeling              O                    O                   
'                    O                    O                   
unwell               O                    O                   
'                    O                    O                   
for                  O                    O                   
3                    O                    O                   
days                 O                    O                   
.                    O                    O                   
History              O                    O                   
of                   O                    O                   
present              O                    O                   
illness              O                    O                   
is                   O                    O                   
consistent           O                    O                   
with                 O                    O                   
a                    O                    O                   
flare                O                    O                   
of                   O                    O                   
coronary             B-DISEASE            O                   
artery               I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
She                  O                    O                   
mentions             O                    O                   
she                  O                    O                   
ran                  O                    O                   
out                  O                    O                   
of                   O                    O                   
amoxicillin          B-MEDICATION         B-MEDICATION        
4                    O                    O                   
days                 O                    O                   
ago                  O                    O                   
.                    O                    O                   
Objective            O                    O                   
:                    O                    O                   
Vitals               O                    O                   
stable               O                    O                   
.                    O                    O                   
Plan                 O                    O                   
:                    O                    O                   
Restart              O                    O                   
amoxicillin          B-MEDICATION         B-MEDICATION        
immediately          O                    O                   
and                  O                    O                   
schedule             O                    O                   
lab                  O                    O                   
work                 O                    O                   
to                   O                    O                   
assess               O                    O                   
specificity          O                    O                   
of                   O                    O                   
coronary             B-DISEASE            I-DISEASE           
artery               I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
markers              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 182:
[CLS]                O                    O                   
Radiology            O                    O                   
Report               O                    O                   
:                    O                    O                   
Chest                O                    O                   
X                    O                    O                   
-                    O                    O                   
ray                  O                    O                   
shows                O                    O                   
patchy               O                    O                   
infiltrates          O                    O                   
consistent           O                    O                   
with                 O                    O                   
colon                B-DISEASE            B-DISEASE           
cancer               I-DISEASE            I-DISEASE           
.                    O                    O                   
Clinical             O                    O                   
correlation          O                    O                   
is                   O                    O                   
recommended          O                    O                   
.                    O                    O                   
Given                O                    O                   
the                  O                    O                   
imaging              O                    O                   
findings             O                    O                   
and                  O                    O                   
clinical             O                    O                   
presentation         O                    O                   
,                    O                    O                   
empiric              O                    O                   
treatment            O                    O                   
with                 O                    O                   
gabapentin           B-MEDICATION         B-MEDICATION        
should               O                    O                   
be                   O                    O                   
considered           O                    O                   
pending              O                    O                   
culture              O                    O                   
results              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 183:
[CLS]                O                    O                   
The                  O                    O                   
62                   O                    O                   
-                    O                    O                   
year                 O                    O                   
-                    O                    O                   
old                  O                    O                   
female               O                    O                   
patient              O                    O                   
with                 O                    O                   
a                    O                    O                   
history              O                    O                   
of                   O                    O                   
hepatitis            B-DISEASE            B-DISEASE           
c                    I-DISEASE            I-DISEASE           
returns              O                    O                   
for                  O                    O                   
routine              O                    O                   
follow               O                    O                   
-                    O                    O                   
up                   O                    O                   
.                    O                    O                   
She                  O                    O                   
states               O                    O                   
that                 O                    O                   
the                  O                    O                   
xarelto              B-MEDICATION         B-MEDICATION        
prescribed           O                    O                   
at                   O                    O                   
the                  O                    O                   
last                 O                    O                   
visit                O                    O                   
has                  O                    O                   
significantly        O                    O                   
reduced              O                    O                   
her                  O                    O                   
pain                 O                    O                   
levels               O                    O                   
.                    O                    O                   
However              O                    O                   
,                    O                    O                   
she                  O                    O                   
is                   O                    O                   
concerned            O                    O                   
about                O                    O                   
potential            O                    O                   
long                 O                    O                   
-                    O                    O                   
term                 O                    O                   
interactions         O                    O                   
between              O                    O                   
xarelto              B-MEDICATION         O                   
and                  O                    O                   
her                  O                    O                   
other                O                    O                   
supplements          O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 184:
[CLS]                O                    O                   
Radiology            O                    O                   
Report               O                    O                   
:                    O                    O                   
Chest                O                    O                   
X                    O                    O                   
-                    O                    O                   
ray                  O                    O                   
shows                O                    O                   
patchy               O                    O                   
infiltrates          O                    O                   
consistent           O                    O                   
with                 O                    O                   
alzheimer            B-DISEASE            B-DISEASE           
'                    I-DISEASE            I-DISEASE           
s                    I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
Clinical             O                    O                   
correlation          O                    O                   
is                   O                    O                   
recommended          O                    O                   
.                    O                    O                   
Given                O                    O                   
the                  O                    O                   
imaging              O                    O                   
findings             O                    O                   
and                  O                    O                   
clinical             O                    O                   
presentation         O                    O                   
,                    O                    O                   
empiric              O                    O                   
treatment            O                    O                   
with                 O                    O                   
dexamethasone        B-MEDICATION         B-MEDICATION        
should               O                    O                   
be                   O                    O                   
considered           O                    O                   
pending              O                    O                   
culture              O                    O                   
results              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 185:
[CLS]                O                    O                   
Radiology            O                    O                   
Report               O                    O                   
:                    O                    O                   
Chest                O                    O                   
X                    O                    O                   
-                    O                    O                   
ray                  O                    O                   
shows                O                    O                   
patchy               O                    O                   
infiltrates          O                    O                   
consistent           O                    O                   
with                 O                    O                   
anemia               B-DISEASE            B-DISEASE           
.                    O                    O                   
Clinical             O                    O                   
correlation          O                    O                   
is                   O                    O                   
recommended          O                    O                   
.                    O                    O                   
Given                O                    O                   
the                  O                    O                   
imaging              O                    O                   
findings             O                    O                   
and                  O                    O                   
clinical             O                    O                   
presentation         O                    O                   
,                    O                    O                   
empiric              O                    O                   
treatment            O                    O                   
with                 O                    O                   
gluten               B-MEDICATION         O                   
-                    I-MEDICATION         I-MEDICATION        
free                 I-MEDICATION         O                   
diet                 I-MEDICATION         O                   
should               O                    O                   
be                   O                    O                   
considered           O                    O                   
pending              O                    O                   
culture              O                    O                   
results              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 186:
[CLS]                O                    O                   
Radiology            O                    O                   
Report               O                    O                   
:                    O                    O                   
Chest                O                    O                   
X                    O                    O                   
-                    O                    O                   
ray                  O                    O                   
shows                O                    O                   
patchy               O                    O                   
infiltrates          O                    O                   
consistent           O                    O                   
with                 O                    O                   
vertigo              B-DISEASE            B-DISEASE           
.                    O                    O                   
Clinical             O                    O                   
correlation          O                    O                   
is                   O                    O                   
recommended          O                    O                   
.                    O                    O                   
Given                O                    O                   
the                  O                    O                   
imaging              O                    O                   
findings             O                    O                   
and                  O                    O                   
clinical             O                    O                   
presentation         O                    O                   
,                    O                    O                   
empiric              O                    O                   
treatment            O                    O                   
with                 O                    O                   
xarelto              B-MEDICATION         B-MEDICATION        
should               O                    O                   
be                   O                    O                   
considered           O                    O                   
pending              O                    O                   
culture              O                    O                   
results              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 187:
[CLS]                O                    O                   
The                  O                    O                   
patient              O                    O                   
,                    O                    O                   
a                    O                    O                   
45                   O                    O                   
-                    O                    O                   
year                 O                    O                   
-                    O                    O                   
old                  O                    O                   
male                 O                    O                   
with                 O                    O                   
a                    O                    O                   
significant          O                    O                   
past                 O                    O                   
medical              O                    O                   
history              O                    O                   
of                   O                    O                   
meningitis           B-DISEASE            B-DISEASE           
,                    O                    O                   
presented            O                    O                   
to                   O                    O                   
the                  O                    O                   
emergency            O                    O                   
department           O                    O                   
complaining          O                    O                   
of                   O                    O                   
worsening            O                    O                   
fatigue              O                    O                   
and                  O                    O                   
shortness            O                    O                   
of                   O                    O                   
breath               O                    O                   
.                    O                    O                   
Upon                 O                    O                   
review               O                    O                   
of                   O                    O                   
systems              O                    O                   
,                    O                    O                   
he                   O                    O                   
noted                O                    O                   
that                 O                    O                   
he                   O                    O                   
has                  O                    O                   
been                 O                    O                   
non                  O                    O                   
-                    O                    O                   
compliant            O                    O                   
with                 O                    O                   
his                  O                    O                   
home                 O                    O                   
medication           O                    O                   
,                    O                    O                   
insulin              B-MEDICATION         B-MEDICATION        
glargine             I-MEDICATION         O                   
,                    O                    O                   
for                  O                    O                   
the                  O                    O                   
past                 O                    O                   
two                  O                    O                   
weeks                O                    O                   
due                  O                    O                   
to                   O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 188:
[CLS]                O                    O                   
Assessment           O                    O                   
and                  O                    O                   
Plan                 O                    O                   
:                    O                    O                   
#                    O                    O                   
sarcoidosis          B-DISEASE            B-DISEASE           
-                    O                    O                   
largely              O                    O                   
controlled           O                    O                   
but                  O                    O                   
recent               O                    O                   
stress               O                    O                   
has                  O                    O                   
caused               O                    O                   
an                   O                    O                   
uptick               O                    O                   
in                   O                    O                   
symptoms             O                    O                   
.                    O                    O                   
We                   O                    O                   
will                 O                    O                   
increase             O                    O                   
the                  O                    O                   
dosage               O                    O                   
of                   O                    O                   
morphine             B-MEDICATION         B-MEDICATION        
from                 O                    O                   
10mg                 O                    O                   
to                   O                    O                   
20mg                 O                    O                   
daily                O                    O                   
.                    O                    O                   
Patient              O                    O                   
was                  O                    O                   
advised              O                    O                   
to                   O                    O                   
monitor              O                    O                   
for                  O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
#                    O                    O                   
Hypertension         O                    O                   
-                    O                    O                   
stable               O                    O                   
.                    O                    O                   
#                    O                    O                   
Diabetes             O                    O                   
-                    O                    O                   
diet                 O                    O                   
controlled           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 189:
[CLS]                O                    O                   
Assessment           O                    O                   
and                  O                    O                   
Plan                 O                    O                   
:                    O                    O                   
#                    O                    O                   
gout                 B-DISEASE            B-DISEASE           
-                    O                    O                   
largely              O                    O                   
controlled           O                    O                   
but                  O                    O                   
recent               O                    O                   
stress               O                    O                   
has                  O                    O                   
caused               O                    O                   
an                   O                    O                   
uptick               O                    O                   
in                   O                    O                   
symptoms             O                    O                   
.                    O                    O                   
We                   O                    O                   
will                 O                    O                   
increase             O                    O                   
the                  O                    O                   
dosage               O                    O                   
of                   O                    O                   
lisinopril           B-MEDICATION         B-MEDICATION        
from                 O                    O                   
10mg                 O                    O                   
to                   O                    O                   
20mg                 O                    O                   
daily                O                    O                   
.                    O                    O                   
Patient              O                    O                   
was                  O                    O                   
advised              O                    O                   
to                   O                    O                   
monitor              O                    O                   
for                  O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
#                    O                    O                   
Hypertension         O                    O                   
-                    O                    O                   
stable               O                    O                   
.                    O                    O                   
#                    O                    O                   
Diabetes             O                    O                   
-                    O                    O                   
diet                 O                    O                   
controlled           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 190:
[CLS]                O                    O                   
Radiology            O                    O                   
Report               O                    O                   
:                    O                    O                   
Chest                O                    O                   
X                    O                    O                   
-                    O                    O                   
ray                  O                    O                   
shows                O                    O                   
patchy               O                    O                   
infiltrates          O                    O                   
consistent           O                    O                   
with                 O                    O                   
gout                 B-DISEASE            B-DISEASE           
.                    O                    O                   
Clinical             O                    O                   
correlation          O                    O                   
is                   O                    O                   
recommended          O                    O                   
.                    O                    O                   
Given                O                    O                   
the                  O                    O                   
imaging              O                    O                   
findings             O                    O                   
and                  O                    O                   
clinical             O                    O                   
presentation         O                    O                   
,                    O                    O                   
empiric              O                    O                   
treatment            O                    O                   
with                 O                    O                   
xarelto              B-MEDICATION         O                   
should               O                    O                   
be                   O                    O                   
considered           O                    O                   
pending              O                    O                   
culture              O                    O                   
results              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 191:
[CLS]                O                    O                   
Subjective           O                    O                   
:                    O                    O                   
Patient              O                    O                   
reports              O                    O                   
feeling              O                    O                   
'                    O                    O                   
unwell               O                    O                   
'                    O                    O                   
for                  O                    O                   
3                    O                    O                   
days                 O                    O                   
.                    O                    O                   
History              O                    O                   
of                   O                    O                   
present              O                    O                   
illness              O                    O                   
is                   O                    O                   
consistent           O                    O                   
with                 O                    O                   
a                    O                    O                   
flare                O                    O                   
of                   O                    O                   
coronary             B-DISEASE            O                   
artery               I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
.                    O                    O                   
She                  O                    O                   
mentions             O                    O                   
she                  O                    O                   
ran                  O                    O                   
out                  O                    O                   
of                   O                    O                   
fentanyl             B-MEDICATION         B-MEDICATION        
4                    O                    O                   
days                 O                    O                   
ago                  O                    O                   
.                    O                    O                   
Objective            O                    O                   
:                    O                    O                   
Vitals               O                    O                   
stable               O                    O                   
.                    O                    O                   
Plan                 O                    O                   
:                    O                    O                   
Restart              O                    O                   
fentanyl             B-MEDICATION         B-MEDICATION        
immediately          O                    O                   
and                  O                    O                   
schedule             O                    O                   
lab                  O                    O                   
work                 O                    O                   
to                   O                    O                   
assess               O                    O                   
specificity          O                    O                   
of                   O                    O                   
coronary             B-DISEASE            I-DISEASE           
artery               I-DISEASE            I-DISEASE           
disease              I-DISEASE            I-DISEASE           
markers              O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 192:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
multiple             B-DISEASE            B-DISEASE           
sclerosis            I-DISEASE            I-DISEASE           
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
jardiance            B-MEDICATION         B-MEDICATION        
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
multiple             B-DISEASE            B-DISEASE           
sclerosis            I-DISEASE            I-DISEASE           
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 193:
[CLS]                O                    O                   
Assessment           O                    O                   
and                  O                    O                   
Plan                 O                    O                   
:                    O                    O                   
#                    O                    O                   
sleep                B-DISEASE            B-DISEASE           
apnea                I-DISEASE            I-DISEASE           
-                    O                    O                   
largely              O                    O                   
controlled           O                    O                   
but                  O                    O                   
recent               O                    O                   
stress               O                    O                   
has                  O                    O                   
caused               O                    O                   
an                   O                    O                   
uptick               O                    O                   
in                   O                    O                   
symptoms             O                    O                   
.                    O                    O                   
We                   O                    O                   
will                 O                    O                   
increase             O                    O                   
the                  O                    O                   
dosage               O                    O                   
of                   O                    O                   
sumatriptan          B-MEDICATION         O                   
from                 O                    O                   
10mg                 O                    O                   
to                   O                    O                   
20mg                 O                    O                   
daily                O                    O                   
.                    O                    O                   
Patient              O                    O                   
was                  O                    O                   
advised              O                    O                   
to                   O                    O                   
monitor              O                    O                   
for                  O                    O                   
side                 O                    O                   
effects              O                    O                   
.                    O                    O                   
#                    O                    O                   
Hypertension         O                    O                   
-                    O                    O                   
stable               O                    O                   
.                    O                    O                   
#                    O                    O                   
Diabetes             O                    O                   
-                    O                    O                   
diet                 O                    O                   
controlled           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 194:
[CLS]                O                    O                   
Emergent             O                    O                   
care                 O                    O                   
note                 O                    O                   
:                    O                    O                   
Patient              O                    O                   
found                O                    O                   
unresponsive         O                    O                   
.                    O                    O                   
Medical              O                    O                   
alert                O                    O                   
bracelet             O                    O                   
indicates            O                    O                   
irritable            B-DISEASE            O                   
bowel                I-DISEASE            O                   
syndrome             I-DISEASE            O                   
.                    O                    O                   
EMS                  O                    O                   
administered         O                    O                   
naloxone             O                    O                   
without              O                    O                   
effect               O                    O                   
.                    O                    O                   
Family               O                    O                   
arrived              O                    O                   
and                  O                    O                   
confirmed            O                    O                   
patient              O                    O                   
takes                O                    O                   
fentanyl             B-MEDICATION         B-MEDICATION        
for                  O                    O                   
the                  O                    O                   
condition            O                    O                   
.                    O                    O                   
Transported          O                    O                   
to                   O                    O                   
ICU                  O                    O                   
for                  O                    O                   
further              O                    O                   
management           O                    O                   
of                   O                    O                   
status               O                    O                   
epilepticus          O                    O                   
secondary            O                    O                   
to                   O                    O                   
irritable            B-DISEASE            O                   
bowel                I-DISEASE            O                   
syndrome             I-DISEASE            O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 195:
[CLS]                O                    O                   
Emergent             O                    O                   
care                 O                    O                   
note                 O                    O                   
:                    O                    O                   
Patient              O                    O                   
found                O                    O                   
unresponsive         O                    O                   
.                    O                    O                   
Medical              O                    O                   
alert                O                    O                   
bracelet             O                    O                   
indicates            O                    O                   
gout                 B-DISEASE            B-DISEASE           
.                    O                    O                   
EMS                  O                    O                   
administered         O                    O                   
naloxone             O                    O                   
without              O                    O                   
effect               O                    O                   
.                    O                    O                   
Family               O                    O                   
arrived              O                    O                   
and                  O                    O                   
confirmed            O                    O                   
patient              O                    O                   
takes                O                    O                   
gabapentin           B-MEDICATION         B-MEDICATION        
for                  O                    O                   
the                  O                    O                   
condition            O                    O                   
.                    O                    O                   
Transported          O                    O                   
to                   O                    O                   
ICU                  O                    O                   
for                  O                    O                   
further              O                    O                   
management           O                    O                   
of                   O                    O                   
status               O                    O                   
epilepticus          O                    O                   
secondary            O                    O                   
to                   O                    O                   
gout                 B-DISEASE            B-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 196:
[CLS]                O                    O                   
Emergent             O                    O                   
care                 O                    O                   
note                 O                    O                   
:                    O                    O                   
Patient              O                    O                   
found                O                    O                   
unresponsive         O                    O                   
.                    O                    O                   
Medical              O                    O                   
alert                O                    O                   
bracelet             O                    O                   
indicates            O                    O                   
multiple             B-DISEASE            B-DISEASE           
sclerosis            I-DISEASE            I-DISEASE           
.                    O                    O                   
EMS                  O                    O                   
administered         O                    O                   
naloxone             O                    O                   
without              O                    O                   
effect               O                    O                   
.                    O                    O                   
Family               O                    O                   
arrived              O                    O                   
and                  O                    O                   
confirmed            O                    O                   
patient              O                    O                   
takes                O                    O                   
gluten               B-MEDICATION         O                   
-                    I-MEDICATION         I-MEDICATION        
free                 I-MEDICATION         O                   
diet                 I-MEDICATION         O                   
for                  O                    O                   
the                  O                    O                   
condition            O                    O                   
.                    O                    O                   
Transported          O                    O                   
to                   O                    O                   
ICU                  O                    O                   
for                  O                    O                   
further              O                    O                   
management           O                    O                   
of                   O                    O                   
status               O                    O                   
epilepticus          O                    O                   
secondary            O                    O                   
to                   O                    O                   
multiple             B-DISEASE            B-DISEASE           
sclerosis            I-DISEASE            I-DISEASE           
.                    O                    O                   
[SEP]                O                    O                   

Example 197:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
hydrochlorothiazide  B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
osteoporosis         B-DISEASE            B-DISEASE           
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
hydrochlorothiazide  B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 198:
[CLS]                O                    O                   
Consultation         O                    O                   
Note                 O                    O                   
:                    O                    O                   
Requested            O                    O                   
evaluation           O                    O                   
for                  O                    O                   
persistent           O                    O                   
hepatitis            B-DISEASE            B-DISEASE           
c                    I-DISEASE            I-DISEASE           
resistant            O                    O                   
to                   O                    O                   
first                O                    O                   
-                    O                    O                   
line                 O                    O                   
therapies            O                    O                   
.                    O                    O                   
The                  O                    O                   
patient              O                    O                   
has                  O                    O                   
previously           O                    O                   
failed               O                    O                   
multiple             O                    O                   
interventions        O                    O                   
.                    O                    O                   
We                   O                    O                   
recommend            O                    O                   
initiating           O                    O                   
a                    O                    O                   
trial                O                    O                   
of                   O                    O                   
jardiance            B-MEDICATION         B-MEDICATION        
,                    O                    O                   
a                    O                    O                   
biologic             O                    O                   
agent                O                    O                   
shown                O                    O                   
to                   O                    O                   
be                   O                    O                   
effective            O                    O                   
in                   O                    O                   
refractory           O                    O                   
cases                O                    O                   
of                   O                    O                   
hepatitis            B-DISEASE            B-DISEASE           
c                    I-DISEASE            I-DISEASE           
.                    O                    O                   
Risks                O                    O                   
discussed            O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 199:
[CLS]                O                    O                   
The                  O                    O                   
62                   O                    O                   
-                    O                    O                   
year                 O                    O                   
-                    O                    O                   
old                  O                    O                   
female               O                    O                   
patient              O                    O                   
with                 O                    O                   
a                    O                    O                   
history              O                    O                   
of                   O                    O                   
sarcoidosis          B-DISEASE            B-DISEASE           
returns              O                    O                   
for                  O                    O                   
routine              O                    O                   
follow               O                    O                   
-                    O                    O                   
up                   O                    O                   
.                    O                    O                   
She                  O                    O                   
states               O                    O                   
that                 O                    O                   
the                  O                    O                   
sertraline           B-MEDICATION         B-MEDICATION        
prescribed           O                    O                   
at                   O                    O                   
the                  O                    O                   
last                 O                    O                   
visit                O                    O                   
has                  O                    O                   
significantly        O                    O                   
reduced              O                    O                   
her                  O                    O                   
pain                 O                    O                   
levels               O                    O                   
.                    O                    O                   
However              O                    O                   
,                    O                    O                   
she                  O                    O                   
is                   O                    O                   
concerned            O                    O                   
about                O                    O                   
potential            O                    O                   
long                 O                    O                   
-                    O                    O                   
term                 O                    O                   
interactions         O                    O                   
between              O                    O                   
sertraline           B-MEDICATION         B-MEDICATION        
and                  O                    O                   
her                  O                    O                   
other                O                    O                   
supplements          O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

Example 200:
[CLS]                O                    O                   
Pharmacy             O                    O                   
note                 O                    O                   
:                    O                    O                   
Clarification        O                    O                   
needed               O                    O                   
for                  O                    O                   
the                  O                    O                   
prescription         O                    O                   
of                   O                    O                   
metformin            B-MEDICATION         B-MEDICATION        
.                    O                    O                   
The                  O                    O                   
dosage               O                    O                   
seems                O                    O                   
high                 O                    O                   
for                  O                    O                   
a                    O                    O                   
patient              O                    O                   
with                 O                    O                   
renal                O                    O                   
impairment           O                    O                   
secondary            O                    O                   
to                   O                    O                   
anemia               B-DISEASE            B-DISEASE           
.                    O                    O                   
Please               O                    O                   
review               O                    O                   
and                  O                    O                   
confirm              O                    O                   
if                   O                    O                   
metformin            B-MEDICATION         B-MEDICATION        
dose                 O                    O                   
needs                O                    O                   
adjustment           O                    O                   
.                    O                    O                   
[SEP]                O                    O                   

